Three Dimensional Printing and Computational Visualization for Surgical Planning and Medical Education by Ryan, Justin Robert (Author) et al.
Three Dimensional Printing and Computational Visualization 
 










A Dissertation Presented in Partial Fulfillment  
of the Requirements for the Degree  











Approved April 2015 by the 
Graduate Supervisory Committee:  
 















ARIZONA STATE UNIVERSITY  
 
May 2015  
ABSTRACT  
  
The advent of medical imaging has enabled significant advances in pre-procedural 
planning, allowing cardiovascular anatomy to be visualized noninvasively before a 
procedure. However, absolute scale and tactile information are not conveyed in traditional 
pre-procedural planning based on images alone. This information deficit fails to completely 
prepare clinicians for complex heart repair, where surgeons must consider the varied 
presentations of cardiac morphology and malformations. Three-dimensional (3D) 
visualization and 3D printing provide a mechanism to construct patient-specific, scale 
models of cardiovascular anatomy that surgeons and interventionalists can examine prior 
to a procedure. In addition, the same patient-specific models provide a valuable resource 
for educating future medical professionals. Instead of looking at idealized images on a 
computer screen or pages from medical textbooks, medical students can review a life-like 
model of patient anatomy.  
In cases where surgical repair is insufficient to return the heart to normal function, 
a patient may proceed to advanced heart failure, and a heart transplant may be required. 
Unfortunately, a finite number of available donor hearts are available. A mechanical 
circulatory support (MCS) device can be used to bridge the time between heart failure and 
reception of a donor heart. These MCS devices are typically constructed for the adult 
population. Accordingly, the size associated to the device is a limiting factor for small 
adults or pediatric patients who often have smaller thoracic measurements. While current 
eligibility criteria are based on correlative measurements, the aforementioned 3D 
visualization capabilities can be leveraged to accomplish patient-specific fit analysis. 
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The main objectives of the work presented in this dissertation were 1) to develop 
and evaluate an optimized process for 3D printing cardiovascular anatomy for surgical 
planning and medical education and 2) to develop and evaluate computational tools to 
assess MCS device fit in specific patients. The evaluations for objectives 1 and 2 were 
completed with a collection of qualitative and quantitative validations. These validations 
include case studies to illustrate meaningful, qualitative results as well as quantitative 
results from surgical outcomes. The latter results present the first quantitative supporting 
evidence, beyond anecdotal case studies, regarding the efficacy of 3D printing for pre-
procedural planning; this data is suitable as pilot data for clinical trials. The products of 
this work were used to plan 200 cardiovascular procedures (including 79 cardiothoracic 
surgeries at Phoenix Children’s Hospital), via 3D printed heart models and assess MCS 
device fit in 29 patients across 6 countries. 
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CHAPTER 1 
INTRODUCTION: CONGENITAL HEART DISEASE AND HEART FAILURE 
 
1.1 The Human Heart 
 
The cardiovascular system transports blood, carrying nutrients, oxygen, and waste products 
to and from cells throughout the body. The cardiovascular system includes the heart and 
its interconnected network of blood vessels. In a normal individual, the heart is comprised 
of two pumps driving two continuous circuits: pulmonary circulation and systemic 
circulation. The right side of the heart accepts oxygen-poor blood from the body via the 
vena cava. The blood then passes through the right atrium, right ventricle, and pulmonary 
arteries before reaching the lungs. The blood is re-oxygenated and returns to the left heart 
via the pulmonary veins. The blood then passes through the left atrium, left ventricle, and 
the aorta before traveling through the rest of the body. In a normal, healthy individual the 
left and right side of the heart are not confluent [1], [2]. An illustration of a normal heart is 
shown in Figure 1. Aberrations of this morphology, either congenital or acquired in origin, 
can affect an individual’s circulatory system’s ability to transport of blood. 
 
1.2 Congenital Heart Disease 
 
Congenital heart disease (CHD) is defined as a morphological aberration of anatomy 
present at birth [2]. While the incidence rates of CHDs are contested [3], some sources put 
prevalence as high as 5.3% of the fetal population and 1.08% of the pediatric population 
  1 
[2]. CHDs may cause significant functional anomalies, needing intervention to correct. 
There are two main categories of CHDs: cyanotic and acyanotic disease. 
 
Figure 1: An anatomical illustration of normal cardiac anatomy. Blue 
colors represent components of the heart containing oxygen-deficient 
blood, while red colors present components containing oxygen-rich blood. 
 
1.2.1 Cyanotic Congenital Heart Disease 
 
Cyanotic congenital heart disease is a broad class of cardiac malformations causing 
oxygen-deficient blood to be returned to the systemic side of the circulation without first 
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being oxygenated in the lungs. This return of oxygen-deficient blood to the arterial 
circulation without oxygenation is also known as right-to-left shunting. 
The shunting can have multiple morphological origins including aberrant systemic 
and pulmonary pathways, elevated pulmonary resistance, and single ventricle anatomy1 
[1]. Aberrant pathways in cyanosis include atrial and ventricular defects where oxygen-
rich and oxygen-deficient blood mixes in addition to abnormal pathways where great 
vessels may be switched from normal presentation. The shunting presents with bluish 
coloration of the patients skin and mucous membrane [1]. An example of Tetralogy of 
Fallot, a cyanotic lesion, is shown in Figure 2. Surgical correction is likely necessary for 
the patient’s ability to survive long term [1], [4]. 
 
1 The following lesions are generally considered cyanotic CHD: transposition of the great arteries, Tetralogy 
of Fallot, heterotaxy, pulmonary atresia with intact ventricular septum, total anomalous pulmonary venous 
return, tricuspid atresia, double outlet right ventricle, truncus arteriosus, and Ebstein’s anomaly. This list is 
not intended to be comprehensive as there are over 3000 lesion types including unique presentations and 
combinations. 
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 Figure 2: Illustration of Tetralogy of Fallot. This cyanotic lesion includes 
4 defects: 1) ventricular septal defect, 2) overriding aorta, 3) pulmonary 
obstruction, and 4) hyperplastic right ventricle. 
 
1.2.2 Acyanotic Congenital Heart Disease 
 
Acyanotic congenital heart diseases are split into two categories: shunted and non-shunted 
acyanotic lesions2. In shunted lesions, oxygen-rich blood bypasses the systemic system and 
returns to the lungs. In non-shunted lesions, blood is obstructed by a morphological 
aberration of the cardiovascular anatomy. Non-shunted lesions often cause increases in 
2 The following classifications are generally considered ayanotic CHD lesions: atrial septal defect, ventricular 
septal defect, atrioventricular canal, patent ductus arteriosus, aortic stenosis, coarctation of the aorta, 
pulmonary stenosis, mitral stenosis, and mitral regurgitation. This list is not intended to be comprehensive. 
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pressure load on a ventricle, as the ventricle must overcome the increase vascular resistance 
from the obstruction [1]. An example of coarctation of the aorta, an acyanotic lesion, is 
seen in Figure 3. 
 
 
Figure 3: Illustration of coarctation of the aorta. This acyanotic lesion 
features an obstructed aortic arch. 
 
1.2.3 CHD Repair & Planning 
 
Some presentations of CHD lesions require surgical intervention early in life. In fact, most 
patients with cyanotic CHD undergo surgery (for repair or palliation) within the first week 
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of life [1]. Despite the latest development in medical technologies and techniques, 
neonates, infants, and children still have high rates of mortality from surgery. 
According to the Fall 2014 data harvest by The Society of Thoracic Surgeons, 
participating hospitals report neonates, infants, and children have mortality rates of 7.7%, 
2.5%, and 1.0%, respectively, following intervention; this figure does not include patient 
mortality indirectly related to surgeries [5]. While these mortality rates have decreased over 
the last 4 years, novel interventions or planning schemes may further reduce surgical 
complications and related deaths. One mechanism for reducing morbidity and mortality in 
the operating room is to reduce the time spent in surgery and the time spent in the operating 
room, as both are related to higher incidences of post-surgical infection [6]. An efficient 
surgical planning scheme may reduce the time-related factors in the operating room, 
minimizing morbidity and mortality associated with complications. 
In order to better plan for CHD intervention, understanding the current mechanism 
for surgical planning is critical. Anatomical variation and physiological aberration can be 
imaged through multiple modalities including echocardiogram, computed tomography 
(CT), and magnetic resonance imaging (MRI) to name a few. While each modality collects 
data through different mechanisms, traditional visualization is through 2D images on a 
screen or printed media. This forced perspective leads the operator or clinician to convert 
the 2D images into 3D volumes in his or her head. The understanding of the spatial 
relationships of complex, diseased anatomy is determined by the visual system of the 
clinician; this process can lead to high errors in reading. Human errors in imaging reading 
and 2D-to-3D visual interpretation could be prevented by providing the user with native 
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3D visualization of the imaging data. Newer imaging systems enable 3D visualization of 
2D medical images [7], [8]. 
Direct volume rendering (DVR) is one 3D visualization technique of 2D data. DVR 
recreates a 3D image similar to a point cloud representation of the 2D slices. Each pixel in 
a 2D image slice is recreated as a point (discrete voxel) and assigned a color value and 
opacity [9]. The effect is a ghost-like image where different tissues have discrete 
transparency and color values. This process heavily relies on the human visual system for 
real-time interpretation as shown in Figure 4; as such human error is present in the reading 
of DVR medical images. 
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 Figure 4: DVR of a CHD lesion. The histogram illustrates opacity and 
color for the tissues associated intensity value on a CT. 
 
 DVR has limitations to representing tissues of similar intensity value as well as 
limitations to segmenting a single tissue into constituent parts for further analysis or 
interventional planning. In complex CHD repair, accurate imaging and a controlled method 
of visualization are key in conceptualizing the complex anatomy prior to intervention. 
Novel image processing technologies such as image segmentation, surface mesh 
reconstruction, and 3D printing can reduce the amount of conceptualization by the human 
visual system, leading to stronger surgical planning schemes. 
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1.3 Advanced Heart Failure 
 
In the event that CHD repair or acquired cardiac disease repair is insufficient to return 
compensated heart function, the patient may progress to decompensation, or advanced 
heart failure. The American Heart Association defines heart failure as a chronic, 
progressive condition in which the heart is unable to pump enough oxygenated blood to 
meet the body's requirements [10]. Advance heart failure is the final stage in which 
palliative treatments or symptom management is insufficient for patient survival [11]. 
In pediatrics, the largest source of advanced heart failure is dilated cardiomyopathy 
(DCM). This is an acquired disease that may or may not be present in patients with 
congenital malformations. DCM is the enlargement of the left or both ventricles in addition 
to lost contractility of the myocardium [12]. Approximately 1 in 100,000 pediatric patients 
are diagnosed each year with symptoms of DCM in the USA; although, this population 
may be underrepresented [12], [13]. In addition, DCM accounts for 10,000 deaths annually 
[12]. DCM is the primary indication for 65% of heart transplants in children 11-17 years 
of age [13]. Children diagnosed with DCM and decompensated heart failure represent a 
high-risk subgroup, often benefiting from optimal heart failure management and prompt 
evaluation for a heart transplant. 
Each year in the United States, 250,000 people are diagnosed as having advanced 
heart failure; nearly 1% of that figure represents the pediatric population [14], [15]. 
Availability of donor hearts fall far short in meeting the demand needed to treat those with 
advanced heart failure. Only 2,200 donor hearts are available every year with 400 of those 
hearts used for pediatric transplants [14], [15]. In fact, children listed for a heart transplant 
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are subject to the highest waiting list mortality in solid-organ transplant medicine in the 
United States [16]. According to Almond et al., 17% of pediatric patients died while 
awaiting heart transplantation (from 1999 – 2006) [16]. While acknowledging this deficit 
of available donor hearts and to improve patient outcomes and survival, it is critical that 
pediatric patients in advanced heart failure be promptly identified for emergent deployment 
of mechanical circulatory support (MCS) devices while waiting for heart transplantation.  
 
1.3.1 Mechanical Circulatory Support 
 
In the event that donor hearts are unavailable, devices may be used as a stop gap effort to 
extend the patient’s time to receive a heart or return organ function necessary for the 
success of heart transplantation. This process of using a device to extend patient viability 
is known as bridge-to-transplantation or bridge-to-candidacy/decision [17]. MCS devices 
attempt to preserve end-organ function and quickly restore functional status of the 
circulatory system by augmenting or replacing cardiac function. Ventricular assist devices 
(VADs) and artificial hearts, subsets of MCS devices, have been used in the pediatric 
population, since the late 1980s, as a bridge-to-transplantation [18]. VADs augment 
ventricular function by supplementing the ventricular pumping action or completely taking 
on the pumping function. The Total Artificial Heart (SynCardia Systems, Tuscon, AZ)3 is 
an MCS-variant in which the device fully replaces the patient’s ventricles. While no unified 
3 While some media and publications exclude the TAH from VAD classification due to its physical 
replacement of the ventricles, this thesis will utilize International Society of Heart & Lung Transplantation’s 
(ISHLT) classification of the TAH. ISHLT categorizes the TAH as a VAD. 
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database exists that tracks MCS deployment, the International Heart Lung Transplant 
Society provide evidence that MCS use is increasing, especially in pediatric medicine [13]. 
Expanded production of various types of VADs has allowed the technology to 
proliferate in the pediatric population, doubling in the last decade [19]. At present, nearly 
20% of pediatric heart transplant recipients are bridged-to-transplantation with VADs [13]. 
The Total Artificial Heart (TAH) has been approved by the US Food and Drug 
Administration (FDA) as a bridge-to-transplant in patients with severe biventricular heart 
failure [20]. The device replaces the native ventricles and valves, resides in the pericardial 
space, and connects directly to the atria and the great vessels. The TAH provides 
biventricular pulsatile flow similar to normal body circulation. The device and its in situ 
implantation is show in Figure 5. Despite the need for MCS devices in pediatrics, 
development of pediatric-oriented VAD devices has been slow. Novel surgical 
interventions with of adult-oriented devices have been used to address the undersized 
patient’s anatomical restrictions [21]. Until device manufacturers better address pediatric 
needs, visualization techniques can assist clinicians in determining whether a pediatric 
patient can accommodate an adult MCS device as well as plan for potential complications, 
thus expanding the potential population that can benefit from these life-saving devices. 
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 Figure 5A: A photo of the SynCardia 70cc Total Artificial Heart. The 
TAH is comprised of two mechanical ventricles. Figure 5B illustrates the 
in situ implantation. Inflow and outflow cuffs attach the mechanical 
ventricles to the right atrium and pulmonary artery for the right device and 
left atrium and aorta for the left device. Images Courtesy: SynCardia 
Systems, Inc. 
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CHAPTER 2 
PHYSICAL MODELING OF CONGENITAL HEART DISEASE 
2.1 Introduction: Current Challenges in CHD Surgical Planning 
 
Pre-procedural planning has long been one of the most challenging aspects of 
cardiovascular surgery and intervention. The reason for this is simple: the cardiovascular 
anatomy is isolated, internal to the body and is not easily accessible prior to the start of a 
clinical procedure. The advent of medical imaging and image processing technologies have 
enabled significant advances in pre-procedural planning, allowing cardiovascular anatomy 
to be visualized noninvasively before an operation. However, pre-procedural planning 
based on images alone does not convey any tactile information and fails to completely 
prepare surgeons and interventionalists. 
The surgical repair of complex congenital heart disease (CHD) or advanced heart 
failure is extremely challenging as the surgeon must consider the extraordinary number of 
variations and presentations of cardiac morphology including malformations. 
Traditionally, surgical and interventional planning was based on ultrasound or catheter-
guided x-ray; the resulting images were two-dimensional (2D) slices or projections of 
patient anatomy. As interventions were unique to each morphological presentation of a 
lesion, clinicians would have to translate 2D images to three-dimensional (3D) structures 
in their head. The intervention would proceed with this conceptual 3D reconstruction from 
acquired 2D images. 
The use of 3D visualization through DVR to plan for complex cardiovascular 
surgery has been well developed over the previous two decades [8]. An example of DVR 
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from a CT scan is seen in Figure 6. Volumetric rendering has its own limitations. Without 
a novel viewing system, the 3D reconstruction are viewed on a 2D dimensional screen. 
True 3D perspective is lost due to this viewing limitation. In addition, absolute size is lost 
in the viewing of a 3D model on a computer screen. However, 3D visualization coupled 
with 3D printing provide a mechanism to construct patient-specific, scale models of 
cardiovascular anatomy that surgeons and interventionalists can examine prior to a 
procedure. These 3D printed models, or physical heart defect models (PHDMs), are 
perceived to be a novel tool with the potential of enhancing surgical planning procedures. 
 
 
Figure 6A: Contrast-enhanced CT scan of a CHD patient. Figure 6B: A 
DVR reconstruction developed from the CT scan. 
 
Prior works have developed mechanisms for improving automated means of 
reconstructing CT and MR images as 3D volumes. The result are 3D models that more 
accurately represent the actual patient’s morphology. Prior works have also explored the 
use of 3D printing for various purposes including 1) surgical planning, 2) content-
knowledge medical education, 3) procedural-knowledge medical education, and 4) family 
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consultation, to only name a few [22]–[24]. With regards to surgical planning models, 
patient geometry has been printed in multiple modalities and materials to help a clinician 
plan a complex intervention. However, few studies present a methodology of using 3D 
printing for surgical planning enhancement in a true clinical integration framework. In fact, 
this work presents the first strong evidence beyond anecdotal cases for the efficacy of 3D 
printing for cardiac surgical enhancement. 
 
2.1.1 Technology Acceptance Model in Medicine 
 
According to Davis et al., the voluntary use of a technology is described as technology 
acceptance [25]. Accordingly, a technology acceptance model (TAM) is one of the 
established methods of examining the behavioral intention of or intent to adopt a new 
technology. The foundational TAM looks at perceived usefulness and perceived ease of 
use to describe behavioral intention associated to a specific technology [25]. Perceived 
usefulness is the perception that using the particular technology will be advantageous over 
the status quo. Perceived ease-of-use is the perception that the utilization of the new 
technology will be relatively non-obtrusive to implement. Both of these aspects are 
influenced by the attitude of an individual in relation to the technology. Attitude is the 
behavioral response to adopting the new technology. TAM is an attempt to quantify these 
behavioral responses either for understanding users’ intent or to inform future design 
iterations. TAM has been expanded to include additional behavioral intention influences, 
known here as “adjustments” such as enjoyment, intention to use, and awareness; these 
adjustments are subsets of perceived ease-of-use [26], [27]. All of these subjective 
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behavioral metrics are affected by external variables. These variables can be related to an 
individual such as prior beliefs or general attitude (not related to attitude regarding the 
technology). The TAM construct can be seen in Figure 7. 
 
 
Figure 7: Technology acceptance model. The TAM investigates a user’s 
behavioral intention to use a technology.  This behavioral intention can be 
broken down to perceived usefulness and perceived ease of use. The user’s 
attitude could be affected by external variables such as user’s 
preconceptions. The TAM initially described by Davis et al. was later 
amended to include additional behavioral adjustments (shaded box). 
 
TAM has been utilized in many fields including information technology, workforce 
management, and medicine [28]–[30]. An 88-study meta-analysis conclude that the TAM 
is a valid and robust predictive model of behavioral intention. The model was found to be 
considerably more effective in describing intention when the respondents were a 
professional cohort as opposed to a general population cohort [29]. Considering past 
studies and this meta-analysis, a professional cohort of cardiothoracic surgeons should be 
able to yield meaningful results on the behavioral intention to use PHDMs. 
Without the perception of efficacy, defined by behavioral intention, the physical 
modeling of a patient’s morphology would fail to be adopted into standard clinical practice. 
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To probe the cardiothoracic surgeons’ technology acceptance of the PHDMs, a post-
surgery assessment was implemented in the standard clinical care process at a collaborating 
institution. The post-assessment examined both perceived usefulness and perceived ease-
of-use. To minimize workflow disruption in the clinical environment, TAM adjustments 
were not considered for this study. The techniques for developing the model, the 
educational study, and the associate advantages and disadvantages are discussed. 
 
2.2 Methods: PHDM Construction 
 
2.2.1 Patient Identification and Image Acquisition 
 
Through the course of clinical care, cardiothoracic surgeons and cardiologist, at a 
collaborating pediatric hospital, identified 79 cases as candidates to receive a PHDM for 
surgical planning. The selection criteria was based on available image data in addition to 
perceived complexity of the anatomy (complex cases were more likely to produce a PHDM 
for surgical planning). For analysis purposes, the inclusion criteria was further defined as 
patients with a primary diagnosis of one of the following CHD lesions: 1) pulmonary 
atresia (ventricular septal defect variant), 2) Tetralogy of Fallot (pulmonary atresia and 
absent pulmonary valve variants), 3) double outlet right ventricle (transposition of the great 
arteries variant), 4) truncus arteriosus, 5) vascular rings, and 6) single ventricle. This 
restricted inclusion criteria truncated the cases for analysis to 33 cases. 
Per standard-of-care, the 33 patients received a contrast-enhanced CT scan. The 
contrast agent illuminated blood volumes in CT image slices, enabling the differentiation 
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of cardiovascular anatomy from extra-cardiac anatomy as shown in Figure 8A. Spatial 
resolution of the CT datasets varied from patient-to-patient. Slice thickness (resolution in 
z-direction) commonly ranged from 0.325mm to 0.9mm; pixel spacing (resolution in x- 
and y-direction) ranged from 0.325mm to 0.625mm. Although less common to the PHDM 
process, MRI was used for 5 cases; although, only one such case was present in the 
restricted inclusion criteria. The MRI datasets lacked the spatial resolution found in the CT 
datasets. Voxel sizes for the MRI-based cases were as high as 2.5mm x 2.5mm x 2.5mm. 
The resulting images were packaged into Digital Imaging and Communication in Medicine 
(DICOM) files. The DICOM file format contains both the images that define the patient’s 
anatomy as well as metadata. The metadata includes crucial information needed for the 
subsequent computational reconstruction such as voxel resolution. 
 
2.2.2 Computational Reconstruction 
 
The DICOM files were imported into Mimics Innovation Suite (Materialise, Lueven, 
Belgium), a medical image processing software suite. The software facilitated image 
segmentation, the process of separating regions of an image into discrete subsets. For 
common cardiac anatomy, the following blood volume subsets were segmented: left atrium 
(including pulmonary veins), right atrium (including vena cava), left ventricle, right 
ventricle, pulmonary arteries, aorta, and coronary arteries. Additional subsets were needed 
in instances where addition, anomalous structures were present (i.e., patent ductus 
arteriosus, aberrant vessels, etc.). The segmentation process produces binary masks of each 
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subset on each CT slice as shown in Figure 8B. These masks were reconstructed into three-
dimensional (3D) surface mesh models. 
 
 
Figure 8A: Contrast-enhanced CT scan. B) Masked subset from CT scan. 
The mask is of the right ventricle. 
 
 Computational cardiac anatomies were then imported into a 3D engineering 
software suite, Geomagic (3DSystems, Rock Hill, SC, USA), for additional post-
processing. In order to better utilize the human visual system, the cardiac subsets were 
differentiated via a standardized color scheme as defined in Table 1. Generally, the right 
heart (including vena cava, right atrium, right ventricle, and pulmonary arteries) were 
colored with blue hues. The blue coloration signified structures containing oxygen-poor 
blood in a normal heart. Conversely, the left heart (including pulmonary veins, left atrium, 
left ventricle, and aorta) were colored with red hues signifying structures containing 
oxygen-rich blood in a normal heart. The color scheme was maintained even in cases were 
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the oxygen-nature of the blood was uncertain or reversed (such as cases of transposition of 
the great arteries). For patient-tracking purposes, each virtual model was labeled with a 




Figure 9: Left: The surface mesh based on a reconstruction is shown. Green 
outlines highlight the polygonal construction of the virtual model. Middle: 
a surface shaded model is shown. Morphological differentiation is 
perceived to be difficult. Right: The final colored surface mesh model. 
Colors differentiate the components of the heart based on a standardized 
color scheme in Table 1. 
 
Geomagic also ensured 3D print viability by confirming that the mesh conformed 
to a water-tight standard4. The resulting models were packaged in a Virtual Reality Markup 
4 A surface mesh is comprised of 2D, polygonal (commonly triangular) elements describing the surface of 
an object. In instances where holes, intersecting polygons, or overlapping polygons exist on the surface, the 
mesh is not considered water-tight as there is no consistent computational definition for what is interior and 
exterior to the model. For 3D printing, this topological error results in uncertainty for what areas should be 
printed or excluded. 3D printing failures or inconsistencies are common in the presence of a non-watertight 
manifold. 
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Language (VRML2.0) file. This file format allows for color information to be retained. A 
final computational rendering is shown in Figure 10. 
Table 1: The standardized color scheme was developed in conjunction with 
a radiologist at St. Joseph’s Hospital and Medical Center. 
 
Anatomical Structure(s) Color RGB Values Hex Value 
Aorta Red  255:000:000 FF0000 
Left Atrium Bright Pink  255:030:164 FF1EA4 
Left Ventricle Light Red  255:105:105 FF6969 
Pulmonary Arteries Dark Blue  000:000:225 0000FF 
Right Atrium & Vena Cava Turquoise  000:255:255 00FFFF 
Right Ventricle Lavender  145:112:255 9170FF 
Anomalous Structure Green  000:255:000 00FF00 
Coronaries Light Orange  255:172:064 FFAC40 
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 Figure 10: A computational reconstruction of a patient's congenital heart 
defect. The defect is Tetralogy of Fallot with multiple aorto-pulmonary 
collateral arteries. The standardized color scheme has been applied. 
 
2.2.3 3D Printing and Post-Processing 
 
Computer numerical control (CNC) cutting is a subtractive manufacturing process in which 
a physical object, based on a computer model, is created by selective removal of media 
from a work piece such as wood, metal or plastic. This process lacks the degrees-of-
freedom needed for printing complex cardiovascular geometries. Accordingly, an in-house 
process was used to construct patient-specific PHDMs, using additive manufacturing – also 
known as 3D printing – technologies. This manufacturing process generates a physical 
object, based on computer model, through the deposition of media. 
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For the developed process, the color-coded computational models were 3D printed 
with a gypsum-based powder media in a zPrinter 650 (3D Systems, Rock Hill, SC, USA) 
3D printer. This 3D printing technology uses a full cyan-magenta-yellow-key-ink (CMYK-
ink), cyanoacrylate infiltration system. The printer deposits a 0.1 mm thick, flat layer of 
gypsum powder on a build platform. Print heads jet a cyanoacrylate binding agent and 
colorant onto the gypsum layer. The build platform drops 0.1 mm and the entire process is 
repeated continuously until the PHDMs have been fully printed. A schematic of the specific 
3D print technology used can be seen in Figure 11.  
 
Figure 11: Schematic of the inkjet 3D printing process. A roller spreads a 
layer of powder on the build platform. A CMYK ink-cyanoacrylate print 
cartridge binds the single layer of powder together through inkjet 
deposition. The build platform lowers and the process is continuously 
repeated until the 3D print is complete. 
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Following removal from the 3D printer, the PHDMs were coated with three layers 
of clear enamel. Aerosolized coatings prevented surface inconsistencies while promoting 
even enamel distribution. Application of the first layer was enhanced with 20 mmHg 
vacuum pressure via a vacuum chamber. The vacuum-enhanced coating promoted enamel 
infiltration into the porous model media, thereby increasing durability and improving 
surface aesthetics. A final PHDM used for surgical planning is shown in Figure 12. 
 
 
Figure 12: A fully-developed PHDM prior to use in a surgical 
consultation. 
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2.2.4 Design Modification 
 
The design of any medical device undergoes an iterative process utilizing user feedback in 
subsequent design modifications. The PHDMs are no exception to this engineering design 
process. In fact, over the 5 years of surgical integration, the PHDMs have had many design 
modifications to address encountered challenges to use. Table 2 is an abridged list of 
requirements and design modifications. 
Table 2: Design modifications for the PHDMs to address clinical needs. 
 Engineering requirements Design modifications 
A Production Time: A PHDM must 
be able to be completed within an 
emergent timeframe 
• Integrated workflow into clinical 
environment to get immediate feedback 
on computational modeling 
• Moved structure differentiation from 
2D segmentation to 3D modeling 
• Utilized on-site clinical image software 
system to decrease segmentation time 
B Durability: The PHDM to 
withstand the hostile user (i.e., the 
clumsy cardiologist) 
• Added support structures to 
unsupported vessels, such as coronary 
arteries 
• Coated models in layers of clear enamel 
C Product Aesthetic: The PHDM 
must function as an educational 
tool (as validated by education 
studies), but also be appealing to 
families (not be rejected by the 
patient-family) 
• Established strict RGB values for 
PHDMs for consistency 
• Coated models in layers of clear enamel 
 
D Longevity: The PHDMs must be 
tracked for future patient anatomy 
analysis or education studies 
• Developed numbering scheme for case 
tracking 
• Printed labels on models 
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2.2.5 Model Validation 
 
Each final PHDM used for surgical planning went through an iterative design process 
where a radiologist or cardiologist qualitatively assessed color-coding and anatomical 
accuracy at each modeling stage. When errors were encountered, the models were adjusted 
accordingly and rechecked. Each model was also evaluated by at least one other medical 
professional at the end of the process. Additionally, the virtual and estimated physical 
volumes for the initial 20 models were compared quantitatively with a t-test to verify 
PHDM accuracy. The virtual volumes were obtained directly from Mimics and the estimate 
physical volumes were obtained from 3DPrint (3D Systems, Rock Hill, SC, USA), the 
software that communicates directly with the 3D printer. 
 
2.2.6 Technology Acceptance Model 
 
Following a surgery, the cardiothoracic surgeon completed a TAM-questionnaire. The 
questionnaire was developed considering the constraints of an active, patient-care 
environment. Too many questions would impede clinical care. Four questions, seen in 
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Table 3: The TAM survey and available responses. The survey was placed 
directly into the post-surgical report for every cardiothoracic surgery. 
1. Was a 3D printed model used for the preparation of or during 
surgery/intervention? 
a. Yes (during planning only) 
b. Yes (during surgery only) 
c. Yes (during planning and surgery) 
d. No 
2. In your opinion, did use of the 3D printed model enhance your 
ability to execute a surgical repair? 
a. Yes 
b. No 
3. If no model was used, did you note any additional morphological 
defects or unexpected variations unseen in the standard planning 
process? 
a. [Free text response] 
4. Please provide any additional information describing the impact 
of the 3D printed model during the planning or execution of this 
patient's surgery? 
a. [Free text response] 
 
For every CHD patient that underwent cardiothoracic surgery, the associated surgeon 
would complete the questionnaire following surgery. A qualitative and limited quantitative 
analysis was performed on the anonymized results from the study. 
 
2.2.7 Post-surgical Analysis 
 
Due to the literature-based correlation of surgical length of time to morbidity and mortality, 
the effects of PHDM-based planning were analyzed via a one-way analysis of variance 
(ANOVA). Response variables included 1) operating room length of time (minutes), 
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defined as the time differential from when the patient is wheeled into the operating room 
to the time he or she is wheeled out and 2) case length of time (minutes), the duration of 
the surgery. Direct morbidity and mortality was analyzed via contingency tables (with 
Fisher’s exact test). Response variables included 1) 30 day readmission (yes/no), the binary 
response whether the patient had to be readmitted to the hospital within 30 days of hospital 
discharge, and 2) 30 day mortality (yes/no), the binary response whether the patient died 
post-surgery within 30 days of hospital discharge. 
 
2.3 Surgical Planning Case Studies 
 
Two case studies are presented here to illustrate anecdotal utility of PHMDs for 1) 
interventional planning and 2) patient-family education. 
 
2.3.1 Multiple Aorto-Pulmonary Collateral Arteries Case Study 
 
Tetralogy of Fallot (TOF), pulmonary atresia (PA), and major aorto-pulmonary collateral 
arteries (MAPCAs) need complex interventions, and pre-natal diagnosis allows for 
appropriate peri-partum planning. A patient was diagnosed in utero as presenting with 
TOF/PA/MAPCAs. Cardiac CT scanning with a minimal radiation protocol at 1 day of age 
confirmed this dual pulmonary blood supply from pulmonary arteries and MAPCAs. The 
true pulmonary arteries were hypoplastic and confluent and appeared distributed to all 
major lung segments. 
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3D CT reconstruction and 3D printing were performed to illustrate the absolute, 
anatomic location of the MAPCAs and their relative location in relation to pulmonary 
arteries. The PHDM was utilized in the surgical planning consultation two days prior to 
surgery. On day 7, the patient was transferred to the destination surgical institution. The 
reconstruction and PHDM (available in the operative suite) were used to guide successful 
placement of a large central aorto-pulmonary shunt. In addition, the PHDM was used as a 
map for subsequent coil embolization of 2 of 3 known aortopulmonary collaterals. The 
third was found to be atretic. The PHDM-enhanced planning helped focus catheter-based 
intervention and is perceived to be the reason for reduced fluoroscopy (radiation) time and 
contrast exposure. The central shunt remains in place to promote growth of confluent native 
pulmonary arteries. The patient is awaiting complete repair. 
Based on the clinicians experience with the PHDM, 3D printing of CT datasets may 
provide significant advantages in pre-procedural planning in many additional cases. This 
method can allow for reduction in fluoroscopy time, resulting in lower radiation exposure, 
and may allow reductions in general anesthesia exposure and cardiopulmonary bypass time 
(where present), possibly resulting in lower complication rates. 
The PHDM was also used as a didactic tool to help educate the patient’s parents 
and about their son’s cardiac anatomy and associated malformations. The patient’s mother 
can be seen holding the PHDM in Figure 13. The educational experience was embraced by 
the patient’s family. Surprisingly, the PHDM was utilized as a coping mechanism by the 
family. The mother and father received tattoos of the PHDM. Inclusion of this rapidly 
developing technology within cardiovascular centers needs further study, but has the 
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potential to revolutionize diagnosis, patient-family education, and patient and patient-
family coping mechanisms. 
 
 
Figure 13: A PHDM in the hand of a patient's mother. The patient has 
Tetralogy of Fallot, pulmonary atresia, and major aorto-pulmonary 
collateral arteries. 
 
2.3.2 Hypoplastic Left Heart Syndrome Case Study 
 
Patient-family education is an important component of the clinical care process that is often 
overlooked. A 1 month old male presented with a CHD lesion, single ventricle, at birth. 
Diagnosis of hypoplastic left heart syndrome was confirmed via ultrasound. A contrast-
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enhanced CT scan was performed as part of the clinical care process and as a means for 
surgical planning. The patient’s family was non-english speaking, and the institution’s 
interpreter did not cover the specific language spoken by the family. A non-medical 
interpreter was brought in to explain to the parents the diagnosis and surgical plan for the 
patient. As common to many institutions, a 2D schematic drawing was created to illustrate 
the anatomical malformation. The clinical staff and interpreter observed that the family 
appeared to fail to understand the diagnosis and surgical plan. A PHDM was created of the 
patient’s anatomy and provided to the clinical staff. The interpreter and the clinical staff 
used the PHDM for patient-family education. The family embraced the PHDM as a means 
of patient-family education and asked to keep the model following surgical repair. An early 
surgical palliation was completed successfully. 
 The case study illustrates a role for the PHDM outside the confines of the surgical 
conference room and the surgical suite. The patient-family should not be overlooked as a 
part of the clinical care process. In fact, better education of the patient-families has been 
linked to reduced readmissions and perceived improvement in clinical outcomes [35], [36]. 
The role of PHDMs in patient-family education warrants further study. 
 
2.4 Results of Surgical Planning Study with PHDMs 
 
2.4.1 Model Validation 
 
A gross volumetric comparison of computational model from reconstruction to material 
estimate, by the 3D printer interface, was made for the initial 20 hearts. There was no 
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statistical difference in measured mean between surface mesh model and output of the 3D 
printing software when adjusting for bleed compensation5. An experimental volume 
measurement via displacement was not performed due to porosity of the PHDM media. 
All models were qualitatively validated by a medical professional (cardiothoracic 
surgeon, cardiologist, or radiologist) prior to 3D printing. All models were approved for 
anatomical accuracy from the available medical images. 
 
2.4.2 Surgical Results 
 
Between September 1, 2012 and December 31, 2014, 928 primary-case cardiothoracic 
surgeries took place at a collaborating pediatric hospital. Of these cases, 79 cases received 
PHDMs for surgical planning. Thirty-three cases were identified as being planned with a 
PHDM fitting the restrictive inclusion criteria (Section 2.2.1) for subsequent ANOVA 
analysis. Fitting the same inclusion criteria, 113 cases are identified as being planned 
through traditional (non-PHDM) methods. The effects of PHDM-based planning on the 
operating room length of time and case length of time were analyzed via a one-way 
ANOVA. 
 First, the effect of the PHDM-based planning on the entire block of restricted 
criteria was analyzed as seen in Tables 4 and 5. 
 
5 The 3D printing technology jets a binding agent onto a powder media. Bleed compensation is the hardware’s 
attempt to control error of the binding agent bleeding beyond its initial contact point. In the model validation, 
bleed compensation was the default printing mode. 
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Table 4: ANOVA table illustrating the effect of PHDM-based planning on 
operating room length of time and case length of time. Green cells 
illustrate the lower, preferred mean time for surgeries planned with a 
PHDM. 
Operating room length of time (PHDM vs Traditional Planning): all included 
patients 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 866 865.6 0.07 0.798 
Error 144 1894507   13156.3   
Total 145 1895372    
      
Planning N Mean 
(minutes) 
StDev 95 CI  
Traditional 113 333.5 114.5 (312.2, 354.9)  
PHDM 33 327.7 115.5 (288.3, 367.2)  
 
  
Case length of time (PHDM vs Traditional Planning): all included patients 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 1916 1916 0.18 0.674 
Error 144 1557292 10815   
Total 145 1559208    
      
Planning N Mean 
(minutes) 
StDev 95 CI  
Traditional 113 229.33 101.81 (209.99, 248.66)  
PHDM 33 220.7 111.3 (184.9,  256.4)  
 
Table 5: Contingency tables illustrating the effect of PHDM-based planning 
on 30-day readmission and 30-day mortality. Fisher’s exact test was used 
to determine probability for the rejection of the stated null hypothesis. 







Readm. Total Fisher’s Exact Test 






• Probability of readmission is 
greater for surgeries planned 
with a PHDM 
 
• P-value = 0.1609 
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Mort. Total Fisher’s Exact Test 






• Probability of 30 day mor-
tality is greater for surgeries 
planned with a PHDM 
 
• P-value = 0.5978 











While ANOVA and Fisher’s exact test failed to illustrate PHDM effect with a p-value less 
than 0.05, every response variable trended toward more favorable outcomes for PHDMs. 
As there are many different types of surgeries and associated complexities, surgeries were 
further blocked in order to estimate PHDM effect for specific diagnoses. 
 For example, double outlet right ventricle (DORV) presenting with the 
transposition of the great arteries (TGA) variation cases and well as truncus arteriosus cases 
were analyzed independent of other cases with regards surgical time response variables. 
The ANOVA tables for this analysis are in Table 6 and 7. 
Table 6: ANOVA tables for the effect of PHDM in planning for DORV-
TGA cases. Response variable include operating room length of time and 
case length of time. 
 
 Operating room length of time (PHDM vs Traditional Planning): DORV-TGA 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 28998    28998    2.16 0.179 
Error 8 107185    13398   
Total 9 136184    
      
Planning N Mean 
(minutes) 
StDev 95 CI  
Traditional 8 466.1 121.1 (371.8, 560.5)  
PHDM 2 331.5 67.2 (142.8, 520.2)  
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Case length of time (PHDM vs Traditional Planning): DORV-TGA 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 26368  26368         1.88 0.207 
Error 8 111962    13995   
Total 9 138330    
      
Planning N Mean 
(minutes) 
StDev 95 CI  
Traditional 8 359.4 118.4 (262.9, 455.8)  
PHDM 2 231.0 117.4 ( 38.1, 423.9)  
 
 
Table 7: ANOVA tables for the effect of PHDM in planning for truncus 
cases. Response variable include operating room length of time and case 
length of time. 
Operating room length of time (PHDM vs Traditional Planning): Truncus 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 18371    18371    2.25 0.185 
Error 6 49087     8181   
Total 7 67458    
      
Planning N Mean (minutes) StDev 95 CI  
Traditional 6 452.7 99.0 ( 362.3,  543.0)  
PHDM 2 342.00 7.07 (185.50, 498.50)  
 
  
Case length of time (PHDM vs Traditional Planning): Truncus 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 11267    11267      1.47 0.271 
Error 6 45959     7660   
Total 7 57226    
      
Planning N Mean (minutes) StDev 95 CI  
Traditional 6 321.7 95.9 (234.2,  409.1)  
PHDM 2 235.00 1.41 (83.57, 386.43)  
 
Similar to the ANOVA of the aggregate data, ANOVA of the DORV-TGA subset and 
truncus arteriosus subset have a p-value above 0.05 (not statistically significant); however, 
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trends illustrate decreased operating room and case length of time with PHDM-based 
planning. 
 The other subsets of primary diagnoses revealed similar ANOVA trends. All of the 
subsets failed to achieve a p-value less than 0.05; however, all mean times for operating 
room length of time and case length of time were less when planned with PHDMs in 
comparison to traditional planning methods. In order to maintain brevity in this section, 
the remaining ANOVA tables are in Appendix A. 
 
2.4.3 Technology Acceptance Results 
 
The post-operative TAM survey was placed into the clinical care process on October 14, 
2014. Through the end of the year, 19 cases received survey responses with 4 cases planned 
with a PHDM. 
Favorable responses outweighed other responses in the TAM questions. The 
average TAM score was significantly higher in the perceive usefulness domain as 
evidenced by the responses to TAM question 2 as seen in Table 8. Responses to TAM 
questions 3 and 4 supported both perceived usefulness and perceived ease-of-use through 
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 Table 8: Technology acceptance model survey responses for the utility of 
PHDMs for surgical planning. 
Technology Acceptance Model Survey (19 responses) 
Question: %  Answer 
In your opinion, did use of the 3D printed model enhance your 
ability to execute a surgical repair? (4 applicable cases) 
100%  Yes 
0.00%  No 
If no 3D model was used but CT/MR was used, did you note 
any additional morphological defects or unexpected variations 
unseen in the planning process? (14 applicable cases) 
21.4%  Yes 
78.6%  No 
 
TAM question 1 separates the patient population into the two cohorts: PHDM 
cohort and traditional planning cohort. For surgeries in which a model was available, 
surgeons completed the second question “[D]id use of the 3D printed model enhance your 
ability to execute a surgical repair?” All responses by the surgeons revealed strong support 
for PHDM as a perceived effective tool. In addition, question 3 asks “If no 3D model was 
used but CT/MR was used, did you note any additional morphological defects or 
unexpected variations unseen in the planning process?” Of the available 14 responses, 
surgeons recognized 3 cases where additional or unexpected anatomical presentation 
occurred.  
Due to the lack of negative survey responses (no variance), the survey fails to yield 
statistically significant responses (defined here as a p-value less than 0.05). Despite the 
lack of statistical significance, the available data and anecdotal responses for TAM 
questions 3 and 4 suggest strong potential for the PHDMs role in enhancing pre- and peri-
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operative surgical planning. Discussion of the results and recorded surgeon vignettes from 
free-text responses follows. 
 
2.5 Discussion and Conclusions for Surgical Planning 
 
2.5.1 Impact of PHDM as a surgical tool 
 
The advent of versatile, readily available, and cost-effective 3D printing technology has 
made it possible to create uniquely useful PHDMs. The PHDMs represent complex heart 
anatomy in a true-to-life, physical form that is patient-specific and color-coded with a 
standardized, optimized map. The developed workflow allows for rapid construction of the 
congenital models, sometimes same day as the acquisition of medical images. The models 
were delivered to the weekly pre-surgical planning conference or emergent meetings prior 
to surgery; some models were utilized perioperative in the surgical suite. Examples of the 
finalized PHDMs can be seen in Figure 14. 
 PHDMs are anatomical replicas with a primary intent on educating the surgeon 
about patient-specific morphology. With regards to the restricted-inclusion criteria cases, 
PHDM-planned surgeries consistently resulted in reduced operating room and case length 
of time. The ANOVA tables for the combined case-population and the blocked-case-
populations reveal a potential trend. Every table illustrates that mean time for the operating 
room and case length were less when the case was planned with a PHDM. The reduction 
of these durations may lead to lower morbidity and mortality, especially through the 
reduction of duration-associated infections [6]. The potential reduction of morbidity and 
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mortality achieves the primary goal of this technology: create a better mechanism of 
surgical planning in order to improve patient outcomes. 
 Effects associated to reduced operating room length of time and longer stays due to 
infection and morbidity include patient-related and hospital related costs. Costs related to 
morbidity post-surgery are offset by the patient/patient-family, insurance companies, and 
hospitals. In addition, the time allocated for an operation has an associate costs; either a 
direct cost per time unit or indirect cost per procedure (depending on the hospital’s business 
model)  [31]–[33]. By reducing the time an operation takes, the hospital will save both 
money and resources that would have likely been consumed in a longer operation. PHDMs 
can reduce surgical and room duration and indirectly save individuals or institutions 
resources. 
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 Figure 14: A) PHDM of a normal heart, B) truncus arteriosus, C) TGA, D) 
coarctation of the aorta. 
 
The results of the TAM surveys further suggest that PHDMs are an accepted new 
technology and that PHDMs positively benefited the surgical planning process. While the 
questions were limited in complexity to maintain efficiency of clinical workflow, the 
overall perception regarding utility (responses to question 2) revealed positive behavioral 
attitude and, therefore, intention to use PHDMs in standard of care. To better understand 
the particular behaviors behind the intention to use, responses to qualitative questions 3 
and 4 were analyzed. Findings from the responses suggest that PHDMs benefited the 
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cardiothoracic surgeons in several key areas: 1) improved spatial cognition, 2) improved 
surgical planning, 3) avoided potential pitfalls, and 4) complimented traditional medical 
imaging. 
There was consensus among the cardiothoracic surgeons that PHDM aided in the 
spatial understanding of adjacent anatomical structures. For example, a patient was 
diagnosed with a Tetralogy of Fallot lesion and an aberrant coronary artery. The following 
response to question 3 illustrates the aided spatial awareness that the PHDM provided: 
 
“[W]e needed to understand the relationship between the pulmonary arteries 
and the anomalous coronary arteies [sic], and needed to plan the 
reconstruction of the RVOT6. [T]he 3D model helped understand these 
[relationships.]” 
 
The four-fold morphological defect of Tetralogy of Fallot includes a severely stenosed 
pulmonary artery. The planned intervention for this patient and CHD presentation was a 
surgical palliation including the placement of a shunt between the aorta and pulmonary 
artery. The shunt attempts to normalize pulmonary blood flow and pressures by reducing 
the impact of the pulmonary obstruction inherent to Tetralogy of Fallot. For this particular 
patient, the placement of a shunt was complicated by aberrant coronary arteries which were 
lying in the intended path of the shunt. The accurate PHDM afforded the surgeons the 
ability to plan the surgery with an absolute-scale representation. The representation 
6 Right ventricular outflow tract 
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facilitated the planning of the path for the shunt in order to avoid coronary impingement 
and obstruction. 
 The positive response in the previous anecdote was not an aberration in attitude of 
responses. In fact, the PHDM assisted in the viewing of structures difficult to see in the 
current standard-of-care process. The following response to question 3 illustrates the 
benefit of augmenting the current planning process with a PHDM: 
 
“[The PHDM] helped delineate all anatomic relationships and specifically 
the pulmonary veins which were difficult to see on echo. The model was 
also useful to determine where we would place the Glenn/how to perform 
the surgery.” 
 
This response illustrates utility beyond simple spatial awareness, but also as a tool that goes 
beyond other imaging modalities. The PHDM model helped to visualize vessels that were 
difficult to see in an ultrasound (echocardiogram) due to the patient’s size and low 
pulmonary blood flow. The planning capacity of the PHDM was also illustrated. The Glenn 
procedure involves the redirection of venous blood (from the superior vena cava) directly 
into the pulmonary arteries so that upper limb and head blood can bypass the pulmonary 
obstruction and proceed directly to the lungs for reoxygenation. The procedure entails the 
severing of the superior vena cava from the right atrium and the reinsertion of the vessel 
into the pulmonary artery distal to the obstruction. Understanding the spatial relationship 
between the superior vena cava and the pulmonary artery is essential for the Glenn 
procedure. 
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The PHDMs measured effects on planning (the ANOVA tables) and surgeon 
intention (the anecdotal vignettes) illustrate the role the PHDM had in establishing the 
surgeons’ spatial understanding of the patient’s anatomy by presenting an accurate, 
absolute-scale reference for the specific patient. In addition, the use of PHDM potentially 
reduce surgical and operating room length of time for complex surgeries. Morbidity and 
mortality are suggested to be linked to these time metric [6], a reduction of these times due 
to effective planning may possible with PHDMs. While the ANOVA tables and associated 
TAM vignettes demonstrate the efficacy of the PHDM, the process and final model have 
limitations. 
 
2.5.2 Study Limitations 
 
There are several limitations to the current surgical planning study. While this study is not 
a clinical trial, the outcomes analysis and deployment of the TAM study share several 
attributes of a clinical trial: patient inclusion/exclusion criteria, imaging protocol, and 
surgeons. Accordingly, the analysis of PHDM based surgical planning shared many of the 
clinical trial limitations, specifically the biases that are well recorded in literature [34].  
 First, the method of analysis compared time metrics between surgeries planned with 
PHDM and traditionally-planned surgeries. Surgeries were further blocked into primary 
diagnoses for subsequent analysis. Secondary or tertiary diagnoses that would complicate 
surgeries were not included in the analysis nor were patient qualifiers such as additional 
congenital defects, syndromes, or chromosomal abnormalities. Furthermore, the surgical 
procedure was not a blocking factor for the analysis. The number of and combination of 
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procedures would make trends difficult to observe through traditional ANOVA testing. 
Without a much greater patient population and stricter inclusion criteria, these additional 
factors would confound the ANOVA analysis.  
As for the TAM study, the two cardiothoracic surgeons that utilized the PHDMs 
were not principal investigators in the study; however, the surgeons were aware that the 
intent of the study was to gauge PHDM efficacy for surgical planning. In clinical trials 
where intent is known by the participants, a detection bias may be present [34]. A detection 
bias can occur when the recording of an outcome is subconsciously affected by the 
participants’ preconceptions. Post-surgical responses are an observation of the surgical 
planning process after the completion of a surgery. Observations made in this manner may 
also yield the detection bias as the surgeon may subconsciously be looking for additional 
benefits of the PHDM or disassociating adverse surgical events from the PHDM. Evidence 
of this bias may be present in the 100% positive response rate to the PHDMs perceived 
efficacy. Without a larger sample size and stricter inclusion protocols, the potential for 
detection bias is difficult to control. A multi-site study with pre-, peri-, and post-surgical 
assessments could further limit the detection bias while also revealing more of the habits-
of-mind behind surgeon interaction with a PHDM. 
 PHDMs were already established at the collaborating institution for complex CHD 
cases. Establishing a randomized trial may be seen as unethical as the institution already 
perceived the PHDMs to be effective and part of standard-of-care. For example, cases in 
which morphology was perceived to be complex were more likely to receive a PHDM 
planning, while geometrically simple and low-risk cases were less likely to receive a 
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PHDM for planning. A randomized trial would take the decision away from the surgeons 
who already have the ability to request a model. 
Furthermore, the availability of data for PHDM effectiveness on “simple” cases is 
perceived to be low. The subsequent surveying could have been affected by the reporting 
bias. Reporting bias occurs when interesting or significant events are more likely to be 
recorded. For this study, it is unknown whether a reporting bias positively or negatively 
affected the outcomes. Complex CHD repair entail higher risks than simple CHD 
procedures. PHDMs were used in more complex situations in which the model could be 
seen as a factor for a poor outcome, although clinicians never reported this negative 
observation. To minimize the reporting bias, a randomized, multi-center study where 
PHDMs are not the standard-of-care would be ideal. The rigid protocol with a randomized 
control cohort would yield results with less perceived biases.  
 
2.5.3 PHDM Limitations  
 
The PHDMs have several shortcomings including the current technological capabilities 
and associated ethical implications. In the current iteration, the PHDMs represent only the 
blood volume internal to cardiac structures and the bounding lumen; no valves or other 
complex tissues are represented. This is a limitation largely associated with the medical 
image modality.  
The models included in the study were derived from contrast-enhanced CT scan. In 
CT scans, intensity values seen on an image is derived from the degree of radio-opacity for 
the particular tissue. Intensity values of most thoracic soft tissues are very similar to the 
  45 
values representing myocardium as seen in Figure 15; thus differentiation and 
segmentation of myocardium from surrounding tissues is difficult and time consuming. To 
compensate for this limitation, segmentation and reconstruction from MRI datasets is 
performed. Unfortunately, MRI-based reconstruction has its own limitations, particularly, 
the spatial resolution (the amount of voxels defining a space) is considerably smaller when 
compared to CT scans. PHDMs constructed from MRI data have the appearance of being 
smoothed as a consequence of reduced spatial fidelity as seen in Figure 16. 
 
 
Figure 15: Contrast-enhanced CT scan. Blood volumes have a higher 
intensity value than surrounding soft tissue. The soft tissue muscle of the 
heart (myocardium) is indistinguishable from the extracardiac soft tissue. 
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 Figure 16: The reduced spatial resolution of an MRI image results in a 
blurry picture. The reconstruction from this acquisition results in a 
“smooth” geometric representation. 
Current technological constraints of CT and MRI image modalities restrict 
reconstruction of small, complex structures, such as valves and small vessels. Valves and 
small vessels typically fall within the sub-voxel space; that is a single voxel will represent 
valve tissue as well as surrounding blood volume. The average intensity of this voxel 
appears closer to the intensity of the sounding voxels. These voxels would likely be 
included in the segmented masks for the structures surrounding it rather than its own mask. 
Until CT- or MRI-protocols, image processing techniques, and reconstruction technologies 
enable finer voxel resolution, PHDMs will lack these sub-voxel structures.  
Lastly, the patient’s safety must be taken into account when constructing a PHDM. 
PHDMs printed at a collaborating institution, both within and beyond the confines of the 
TAM study, were largely based on contrast-enhanced CT scans. While CT technology was 
used for increased spatial fidelity for diagnosis (when compared to the available MRI 
technology), CT scans do have the added risk of radiation exposure. The TAM study 
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presented here did not further expose patients to ionizing radiation as all medical images 
were part of the standard-of-care process. MRI, with non-ionizing radiation, is an appealing 
alternative for diagnosis especially as its spatial fidelity is improving due to advances in 
image processing technologies. 
  
2.5.4 Concluding Remarks on PHDMs 
 
Despite these study biases and modeling limitations, the surgical PHDM study 
demonstrates trends for reduced operating room and case length of time. The added benefit 
may be attributed to better surgeon preparedness. This preparedness may yield better 
patient outcomes with lower chances for morbidity and mortality. The utility of planning 
with a PHDM is supported by the TAM study which demonstration that PHDMs for 
surgical planning may increase surgeon familiarity of patient-specific morphology and help 
surgeon plan for a complex CHD repair. A multi-center clinical trial could show the 
measured effect of the PHDM on critical surgical factors such as 30 day outcome, case 
length of time, or cardiopulmonary bypass time. Illustrating reductions in morbidity and 
mortality in patients with CHDs would aid in the acceptance, by the greater medical 
community, regarding the efficacy of PHDM as a surgical planning tool. Acceptance of the 
technology is already high at the collaborating hospital where over 200 hearts have been 
printed for clinical planning. In fact, additional, non-cardiac departments are investigating 
utility of 3D printing for their respective cases. 
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Beyond the pre- and peri-operative surgical enhancement, PHDMs have a potential in 
enhancing medical education. Currently, heart models play an active role in educating 
medical professionals in many roles and at many levels (e.g., pre-medical students, medical 
students, residents, fellows, nurses, etc.). The most basic heart models are 2D diagrams, as 
found in the pages of canonical medical education texts such as Gray’s Anatomy and 
Netter’s Atlas of Human Anatomy [37], [38]. These 2D drawings can only show a single 
view of the cardiovascular anatomy which may not capture all structures necessary for 
complete education. Additional windows or unnatural perspectives can provide additional 
anatomic landmarks; however, the 2D limitation still exists. 
Anatomical dissection is a prominent feature in many medical educational settings. 
Learners investigate the human body through the removal of tissue and exposure of 
anatomical landmarks. This educational method utilizes the human visual system and 
allows a 3D appreciation of structures. However, cadaver specimens have limitations. 
Given an assumption that cadavers represent an analogous, normal distribution sample of 
the living population, it can be assumed that less than 2% of the cadavers will present with 
CHD lesions, and even fewer would present with untreated CHD lesions [4]. This 
specimen-population creates a limitation to learning experiences for specific congenital 
defects. For instance, 7% of the living CHD population (0.13% of the general population) 
are estimated to have Tetralogy of Fallot [1]. This would imply that, at most, only 0.13% 
  49 
of cadavers would present with Tetralogy of Fallot. In this example, very few learners 
would likely interact with a Tetralogy of Fallot cadaver heart, and even fewer learners 
would interact with a Tetralogy of Fallot cadaver heart prior to any surgical intervention. 
While this limitation may be mitigated through long term preservation of specimens, the 
availability of specific defects is still limited in an educational setting. Another cadaveric 
limitation includes the shape and presentation of the deceased’s cardiovascular anatomy 
when compared to a similar, living anatomical specimen. A living patient’s heart would be 
filled with blood as well as be impacted by surrounding tissues. A cadaveric heart would 
not have these features and may, therefore, appear deflated or altered from its natural, in 
situ shape and presentation. To overcome these population and morphological limitations 
inherent to cadaveric specimens, manufactured models can capture the shape of a living 
heart without any concern for an available cadaver population. 
Manufactured models can reproduce specific anatomical malformations for 
targeted learning experiences. More recently, 3D virtual heart models have emerged, 
offering a number of benefits [39]–[41]. Specifically, the 3D nature and interactivity of the 
models benefit spatially advanced and convergent learners, respectively, who are common 
to medical student populations. Those benefits are also offered by physical heart models, 
like the 2500 Heart (GPI Anatomicals, Lake Bluff, IL, USA) and Classic Heart (American 
3B Scientific, Tucker, GA, USA), which provide additional benefits to kinesthetic learners 
because such models can be manipulated by hand. In fact, studies have shown that 
integrating physical heart models into traditional didactic programs helps to access both 
hemispheres of the brain and improves retention [42]. Learning studies specific to CHDs 
have also demonstrated the benefits of using physical heart models [43]. 
  50 
Conventional manufactured models have limitations associated to geometric 
complexity as well as patient specificity. Many of the idealized cardiovascular models are 
produced through a casting process, such as the Classic Heart. While this manufacturing 
technique reduces costs associated with production of numerous models, the mold must be 
idealized to facilitate release of the final cast. This idealization results in the removal of 
undercuts or small unsupported vessels. The geometric simplification results in the loss of 
fidelity and may impact the educational efficacy of the model should too many structures 
be simplified or removed.  
In addition, manufacturing processes are optimized for a run of multiple casts. 
Individualized models, such as from specific defects or unusual case studies, are unlikely 
to be seen as cost effective. To further complicate the fabrication of unique heart models, 
there over 90 different CHD categories and over 3000 possible defect combinations [1], 
[44]. As a result, representative CHD models for medical education are scarcely available. 
Tooling for idealized or patient-specific cardiovascular models can commonly range from 
$25,000-$60,000. 3D printing technologies may be leveraged to overcome both of these 
geometric-related issues. In contrast, the proposed PHDMs can be built to-scale directly 
from any CHD patient’s image data and are fully color-coded with a standardized, 
educationally-optimized map. 
Toward this aim, a study was developed to examine the learning impact and 
technology acceptance of PHDMs for education. Two cohorts were established: nurses 
using PHDMs and nurses using traditional textbook illustrations. The two cohorts received 
the same delivery of content knowledge. A study utilizing pre- and post-assessments 
examined the utility of PHDMs as an educational tool against the textbook status quo. 
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2.6.2 Methods: Education Study 
 
A learner population comprised of nurses from various clinical institutions and departments 
was identified as study participants. Participants were randomized and separated into two 
cohorts: PHDM cohort and traditional (2D drawing) cohort. 
The content knowledge of the study was aimed at the “normal” heart and five major 
CHD classifications: Tetralogy of Fallot, transposition of the great arteries, truncus 
arteriosus, coarctation of the aorta, and hypoplastic left heart syndrome. These CHD 
categories were identified by cardiologists and cardiothoracic surgeons at a collaborating 
institution as the areas of greatest perceived impact in CHD education. 
The education study was designed to be modular and deployable. Toward this aim, 
video modules with associated visual aids were developed for each cohort. Content of the 
videos was established by a collaborating cardiologist and nurse educator. Two sets of 
videos were developed for each heart category. The content knowledge, delivered through 
a narrated script, was kept consistent between the two video sets. However, the videos 
differed with regards to visuals. One set of videos showed photos of PHDMs, while the 
other set featured traditional drawings of CHDs. Screen captures from the videos can be 
seen in Figure 17. 
Non-video, visual aids were also developed for each cohort. The PHDM-cohort 
received 3D prints (PHDMs) of the normal and five related CHDs. The PHDMs were 
scaled for durability, but were otherwise unaltered from patient-specific data. The 2D 
drawing cohort received print outs of drawings used in the videos. The drawings were 
patterned after the canonical textbook illustrations created by the National Center on Birth 
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Defects and Developmental Disabilities (NCBDDD) [45]. Alterations were made to make 
the drawings more analogous to the patient-derived PHDMs. For example, the illustration 
of the hypoplastic left heart syndrome was modified from the NCBDDD drawings to 
enlarge the patent ductus arteriosus to better match the patient-derived PHDM. Color 
schemes used in the illustrations matched the standardized color scheme for the PHDM. 
Since myocardium was present on the illustrations and not the PHDM, the myocardium 
was given a color pattern. Final drawings were verified by a cardiothoracic surgeon and 
nurse educator for anatomical accuracy. 
 
 
Figure 17: Still images from the video modules. A) PHDM of transposition 
of the great arteries. B) Anatomical drawing of transposition of the great 
arteries. 
  
An attempt was made to be modality-agnostic with regards to the cohort-restricted 
videos and visual aids. A pen-and-paper assessment, without any illustrations or photos, 
was created. The questions in the assessment were developed toward eliciting responses 
related to CHD understanding and spatial relationship of anatomical structures. The test 
was used as a pre-assessment to gauge nurse familiarity with CHDs. Following the pre-
assessment, a nurse would sit in front of a laptop or tablet computer and play the videos 
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related to his or her cohort while interacting with the cohort-appropriate visual aids. 
Following the videos, nurses completed the post-assessment with the same content as the 
pre-assessment. An additional section was added to the post-assessment. This additional 
section probed technology acceptance of the PHDMs. A schematic diagram of the study 
seen in Figure 18. 
 
Figure 18: A schematic diagram of the nurse education study. The two 
educational cohorts split for content knowledge delivery, but the schematic 
path converges where the cohorts participate in the same pre- and post-
assessment. 
 
The nurse educational study was performed at one medical center. Fifty-five nurses 
(n=55) participated in the study, where no monetary compensation for participation was 
provided. Department/specialization was recorded as a potential factor affecting 
acquisition of cardiac-focused content knowledge. Two regression models were developed 
to examine three response variables: 1) post-assessment mean grade (𝑦𝑦1), 2) grade 
improvement from pre-assessment to post-assessment (𝑦𝑦2), and 3) the mean corrected 
grade change (𝑦𝑦3). The last response variable is determined through the correction of a 
wrong pre-assessment response to a correct post-assessment response. 
  54 
The main factors and corresponding, coded levels for the regression model were: 
 Factor A: Modality 
2D Drawings (0) 
PHDMs (1) 
 Factor B: Department/Specialization 
 Non-cardiac Specializations (0) 
 Cardiac Specializations (1) 7 
 
The general regression model that was applied to three response variables: 
 
𝑦𝑦1,2,3 =β0 +β𝐴𝐴𝑥𝑥𝐴𝐴 +β𝐵𝐵𝑥𝑥𝐵𝐵+β𝐴𝐴𝐵𝐵𝑥𝑥𝐴𝐴𝑥𝑥𝐵𝐵 + ϵ, (1) 
 
where 𝑦𝑦𝑖𝑖 represents the response variables. 𝑥𝑥𝑖𝑖 represents a factor level value (0, 1), different 
experimental factors are indicated by subscripts (i.e., A and B), the interaction between 
factors are indicated by complex subscripts (i.e., AB). β estimates the effect created by 
factors (where β0 is the grand mean for the learning experiment), and experimental error 





7 Cardiac specializations included nurses working in the cardiovascular intensive care unit (CVICU). 
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2.6.3 Methods – Technology Acceptance Model 
 
A 22 question, expanded-TAM survey was included on the post-assessment following the 
content knowledge test. Questions probed awareness/presence-of-mind, perceived 
usefulness, perceived ease-of-use, enjoyment, generalized attitude, and intention to use. 
The 5-point Likert scale was used for responses to all questions, and a t-test was used to 
determine potential statistical significance of mean responses. 
 
2.6.4 Results of Educational Study with PHDMs 
 
To establish significance of factors (modality of educational aid and specialization of 
nurses), a full ANOVA table of factors and interactions was developed for the mean of 
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Table 9: ANOVA table for the effect of modality and nurse specialization 
on post-assessment score mean. An asterisk denotes statistical significance 
with a p-value less than 0.05. 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
Regression 3 1394.97 464.991 3.34 0.026 
𝑥𝑥𝐴𝐴 1 647.42 547.421 4.65 0.036* 
𝑥𝑥𝐵𝐵 1 260.14 260.143 1.87 0.178 
𝑥𝑥𝐴𝐴𝑥𝑥𝐵𝐵 1 5.26 5.263 0.04 0.847 
Error 51 7096.52 139.147   
Total 54 8491.50    
 
Based on the ANOVA table and using a p-value less than 0.05 for significance, only the 
modality of the educational aid is statistically significant on the mean of the post-
assessment score. Since modality is the only significant factor, a two-sample t-test was 
performed to determine the mean of each group, 2D drawings and PHDMs. The two-
sampled t-test is seen in Table 10. 
Table 10: Two-sample t-test for the difference of mean test scores between 
2D drawings nurse cohort and PHDMs nurse cohort. An asterisk denotes 
statistical significance with a p-value less than 0.05. 
Media n Mean Std. Dev. 
2D Drawings 31 86.9 14.8 
PHDMs 24 94.9 6.82 
Difference (μPHDM -μ2D)  +8.07  
T-Test of Difference p-value 0.010* 
 
The two-sample t-test illustrates significance of the post-assessment means between the 2D 
drawing cohort and the PHDM cohort. 
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 Writing the regression equation with the effects and mean results in the following: 
 
𝑦𝑦1 = 83.67 + 5.82𝑥𝑥𝐴𝐴 + 9.18𝑥𝑥𝐵𝐵 + 1.32𝑥𝑥𝐴𝐴𝑥𝑥𝐵𝐵 + ϵ; (2) 
 
however, as modality is the only statistically significant factor, the regression model can 
be truncated to the single factor. The revised equation follows: 
 
𝑦𝑦1 = 86.87 + 8.07𝑥𝑥𝐵𝐵 + ϵ. (3) 
 
Grade improvement was determined through difference between post-assessment score 
and pre-assessment score. To establish significance of experimental factors for grade 
improvement, an ANOVA analysis was performed. The grade improvement ANOVA table 
is seen in Table 11. 
 
Table 11: ANOVA table for the effect of modality and nurse specialization 
on grade improvement from pre- to post-assessment. Significance was 
determined via a p-value less than 0.05. 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
Regression 3 44.794 14.9313 4.61 0.006 
𝑥𝑥𝐴𝐴 1 8.813 8.813 2.72 0.105 
𝑥𝑥𝐵𝐵 1 11.478 11.4775 3.54 0.066 
𝑥𝑥𝐴𝐴𝑥𝑥𝐵𝐵 1 0.019 0.0192 0.01 0.939 
Error 51 165.315 3.2415   
Total 54 210.109    
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 Based on the ANOVA table and using a p-value less than 0.05 for significance, no factor 
is statistically significant. However, both modality and nurse specialization illustrate trends 
towards educational effect.  Both, PHDM and non-cardiac specialty nurses trend toward 
showing stronger improvement. 
Accuracy of correction was also analyzed with an ANOVA table as seen in Table 
12. 
Table 12: ANOVA table for the effect of media and nurse specialization on 
mean corrected grade change. Significance was determined via a p-value 
less than 0.05. 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
Regression 3 2056.8 685.597 4.03 0.012 
𝑥𝑥𝐴𝐴 1 411.5 411.5 2.42 0.126 
𝑥𝑥𝐵𝐵 1 519.3 519.255 3.06 0.086 
𝑥𝑥𝐴𝐴𝑥𝑥𝐵𝐵 1 2.5 2.457 0.01 0.905 
Error 51 8665.7 169.915   
Total 54 10722.5    
 
Based on the ANOVA table and using a p-value less than 0.05 for significance, no factor 
is statistically significant on the accuracy of correction. Both, PHDM and non-cardiac 
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2.6.5 Results from Technology Acceptance Study 
 
The responses of the 55 nurse participants were generally favorable responses. The average 
TAM score for cardiac specialized nurses was higher in the usefulness domain; however, 
non-specialized nurses showed a higher attitudinal (positive) response to the PHDMs. 
Table 13 (following page): Technology acceptance model survey including 
mean responses and standard deviations for the PHDM cohort. The percent 
difference between PHDM TAM response and traditional TAM response 
are recorded. Mean difference percent is highlighted in green when found 
to be statistically significant according to a two-sample t-test and a p-value 
less than 0.05; otherwise, the value is highlighted in yellow. 
Technology Acceptance Questions Score Mean 
 Mean ± Std. Dev. Difference 
Awareness/Presence     
The drawing/model helps me understand the 
defect. 4.33 ± 0.70 +23.24% 
The drawing/model helps me understand the 
spatial relationship of cardiovascular structures. 4.38 ± 0.77 +31.67% 
The patient derived drawings/models helps me 
appreciate anatomical variations. 4.17 ± 0.70 +24.20% 
Perceived Usefulness     
The drawing/model improved my understanding 
with regards to spatial relationship of anatomy. 4.08 ± 0.72 +21.71% 
The drawing/model in conjunction with the video 
improved my understanding with regards to spatial 
relationship of anatomy. 
4.08 ± 0.65 +24.10% 
The drawing/model improved my understanding 
with regards to congenital heart defects. 4.25 ± 0.85 +21.99% 
The drawing/model in conjunction with the video 
improved my understanding with regards to 
congenital heart defects. 
4.21 ± 0.83 +20.79% 
The educational module gave me a greater 
confidence in explaining congenital heart defects 
to patient-families. 
3.88 ± 0.85 +15.50% 
What I have learned in the educational module will 
impact my patient care. 3.54 ± 0.88 +05.57% 
The educational module was an effective use of my 
time. 4.00 ± 0.72 +21.57% 
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Technology Acceptance Questions Score Mean 
 Mean ± Std. Dev. Difference 
Perceived Ease-of-Use     
The drawing/model was easy to understand. 3.50 ± 0.66 -01.36% 
This video was clear. 4.13 ± 1.02 +14.17% 
The module did not take an unnecessary amount of 
time to complete. 4.04 ± 0.99 +01.04% 
The module was effective with some instruction. 4.04 ± 0.86 +09.90% 
The module would be effective without any 
instruction. 2.75 ± 0.69 +00.29% 
Enjoyment     
I enjoyed this module as an educational tool. 4.21 ± 0.88 +19.69% 
I enjoyed this module regardless of the potential 
educational value. 4.00 ± 0.93 +14.81% 
Attitude     
The module will improve my clinical care. 3.75 ± 0.90 +06.65% 
I have a positive attitude about this module. 4.17 ± 0.82 +11.35% 
Intention-to-Use     
The module encourages me to learn more about 
congenital heart disease. 4.21 ± 0.78 +07.82% 
I wish modules like this were created for other 
common anatomical variations. 4.38 ± 0.77 +20.02% 
I would recommend this module for other clinical 
care professionals. 4.21 ± 0.98 +19.69% 
 
2.6.6 Discussion and Conclusions 
 
Many physical and illustrative models exist of the normal human heart [37], [44]. 
As such, it was expected that the nurses would have a similar educational background and 
similar fundamental understanding of the human heart. Responses to questions8 1 and 2 of 
the content knowledge portion of the assessments that probed understanding of normal 
anatomy were equal between the cohorts at 100%. This suggests that the assumption of 
foundational knowledge is correct. The focus of the assessments, therefore, was on the 
8 Please see Appendix B for a full copy of the nurse learning assessment. 
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development of knowledge of CHD with an emphasis of spatial understanding. Attempts 
were made to make all delivered content knowledge homogenous between the two cohorts. 
For example, video content and color information were kept consistent between the two 
cohorts. 
 Overall, the PHDM cohort achieved a higher mean score (p-value=0.036) and 
improved score (not statistically significant) in the education study. From the post-
assessment ANOVA table (Table 9) and the two-sample t-test (Equation 1), the effect of 
media (2D Drawings or PHDMs) is significant on the grade means. In addition, the mean 
grades are statistically greater from the PHDM cohort than the 2D drawing cohort. The 
PHDM cohort was able to consistently achieve grades that were 8% higher than the 
opposing cohort. The PHDM, on a surface level, appear to be a significantly better 
educational tool than textbook illustrations. Analysis of specific answers suggests reasons 
for the learning differences between the cohorts. 
Physical, 3D models are able to more accurately represent complex 3D structures 
such as CHD. Questions 5 and 9 focused on spatial relationships between cardiovascular 
structures in the presence of CHD. In transposition of the great arteries, the pulmonary 
artery and the aorta are switched at the morphological origin. In conventional anatomical 
positioning, the aorta becomes the most anterior great vessel.  Both mean score and mean 
differential trended higher in the PHDM cohort than the 2D cohort. These results illustrate 
the 2D drawings are less effective at communicating spatial relationships. 
The collective results make it clear that the proposed use of PHDM offer unique 
benefits. Similar trends were observed in an additional CHD-related education study [22] 
and in another study involving nursing students (i.e., the color-coded physical heart model 
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variant was most effective in both studies); however, the sample size in this earlier study 
was too small to establish statistical significance. 
Additional findings, while not statistically significant, illustrate learning trends. 
The improvement from pre- to post-assessment (mean differential grade) for the PHDM 
cohort was greater than 7% for non-cardiac specialties (p-value=0.126). Similarly, non-
cardiac specialties, learning with the PHDMs, were more likely to change a wrong answer 
to a correct answer (p-value=0.105). These data points suggest that nurses in cardiac 
specialties were set in their content knowledge, whether correct or incorrect in the 
responses. This data also suggests that the PHDMs may be a more effective tool for non-
cardiac specialized nurses, nurses earlier in training (prior to career differentiation), or pre-
graduate nurses. 
This evidence for educational impact may help the development of future 
educational programs that best target learning habits of specific demographics. This can be 
achieved through the optimization of the regression model presented in Equation 1. That 
model can be used to optimize the learning outcomes of specific demographics of medical 
curricula (i.e., maximize the response variables, Y, in Equation 3) by adjusting the key 
categorical level values (i.e., those for factors A and B). Through implementing the coded 
values, post-assessment mean scores are greatest with A=PHDM and B=cardiac 
specialized nurses. However, while not statistically significant, improvement of grades, 
implying development of content knowledge, is best achieved though A=PHDM and 
B=non-cardiac specialized nurses as the educational cohort. 
While the value added by the PHDMs’ physical form is relatively straight forward, 
the proposed color-coding standard adds value in more subtle ways. First, the standard is 
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consistent across all models in the PHDM library, and accordingly facilitates the 
identification of common structures among different models. Second, the standard allows 
vessels carrying oxygenated blood to be easily distinguished from those carrying 
deoxygenated blood in non-shunted anatomy, thereby communicating physiology in 
parallel with anatomy. Third, abnormal vessels are also made easily identifiable by 
leveraging characteristics of the human visual system; abnormalities are highlighted in 
green against the largely blue and red pallet of the rest of the heart. The proposed color-
coding, thus, allows an observer to glean information quickly from a specific model, which 
facilitates improved recognition and/or understanding of heart anatomy. In fact, a related 
study demonstrated significant educational benefits when the color-coding standard was 
applied to computational models of CHDs instead of a monochrome or random color 
scheme [46]. As the current education study showed, the color-coding can also be applied 
in parallel with physical modeling to further enhance learning. Besides strict content 
knowledge development analysis, it is critical to examine the technology acceptance of this 
novel tool for education. For this study, the TAM was developed in the post-assessment 
through 22 questions; the mean responses to these questions are in Table 13. In the domain 
of perceived usefulness, two questions probed the participant’s perception of the PHDM 
as an effective tool. Mean responses to both questions were statistically greater (two-
sampled t-test) than the mean responses to the 2D drawings. Besides the added spatial 
characteristics, participants perceived the PHDMs to better convey content knowledge of 
CHD. 
For direct perceived ease-of-use, no response means for PHDMs were statistically 
greater than 2D drawings; however, qualitative characteristics can be observed. The video, 
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the mechanism for content knowledge in this study, was perceived to be effective and an 
efficient use of time. Low differences between the cohorts is likely due to the group having 
the same content delivered, only the visual aid differentiated the two cohorts. 
Indirect (or extended) ease-of-use domains illustrated a mixture of statistically 
significant and non-significant responses. Of the significant responses, the PHDM cohort 
perceived the study to be enjoyable as an education tool. This feature is significant to 
technology acceptance according to the expanded TAM models [47]. In the intention-to-
use domain, participants stated their desire for the educational experience and 3D models 
to be translated to other anatomies and anatomical variations. Further illustrating the 
positive outlook for the educational experience was the participants’ high grade of 
likelihood to recommend the educational experience with PHDMs to other clinical 
professionals. 
The TAM attempts to understand the adoption of a new technology and 
incorporates both perceived usefulness and perceived ease of use [25]. Additional domains 
have been expanded by subsequent research to additional behavioral outlooks such as 
enjoyment, attitude, and intention to use [47]. The PHDMs excelled as a tool likely to be 




The PHDMs and associated study both have limitations. First, the PHDMs are developed 
through a multi-disciplinary research initiative. This complex development process utilizes 
advanced imaging software and the latest in 3D printing technologies. Both software and 
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hardware needed to construct the PHDMs are expensive to purchase and maintain. The 
PHDMs are estimated to cost around $75 in materials. These advanced educational 
materials cost considerably greater than color textbook illustrations or mass-produced, 
idealized heart models. 
 To address these concerns, a mixed manufacturing approach may significantly 
reduce the creation an operating costs for educational material development. 3D printing 
can be utilized to develop mold for many casting processes. Casting instead of 3D printing 
for every model will significantly drive down costs of manufacturing. 
 The study also has limitations. While some aspects of the educational study 
achieved statistical significance (observed here as a p-value<0.05), not all aspects of the 
study achieved this threshold. For example, 3 of the 52 participants were male. 
Understanding learning habits between sexes may enhance the PHDM educational 
efficacy. For instance, one sex may benefit by 3D anatomical representations over the other 
sex. The study performed was unable to make this distinction. 
 In addition, the study was performed with two participant groups. Groups were 
separated into different rooms to watch the video series. While a proctor was present in the 
room to prevent nurses from communicating, an ideal environment would be a single 
participant isolated in one room for the duration of the study. Despite these limitations, the 
trends observed in assessments provide a promising future for PHDMs in clinical 
education. 
 Lastly, the study focused on the content knowledge differences between the two 
groups of learners. The study did not focus on the habits of mind with regards to how the 
learners interacted with PHDMs. A protocol analysis educational study could address these 
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learning behaviors. In-depth interviews before, during, and after the learning modules may 
help to describe the role the PHDMs have in the learning process. By better understanding 
the educational mechanisms behind the PHDMs, the models can be refined to better meet 
the needs of the greater medical education community.  
 
2.7 Concluding Remarks 
 
This study investigated the effects of PHDMs in an educational environment by engaging 
with nurse participants in an educational experience. Experimental results showed that 
nursing cohorts that learned with PHDMs performed better on modality-agnostic tests than 
cohorts that learned with 2D drawings. Furthermore, PHDMs achieved higher ratings in 
perceived usefulness and perceived ease-of-use than 2D drawings in a TAM survey. These 
results are promising for the adoption of PHDMs in the nurse education environment. 
Additional studies will be needed to determine if the results of this study can be 
extrapolated to other medical educational environments or even non-medical educational 
environments.  
  67 
CHAPTER 3 




The SynCardia 70cc TAH, an MCS device, is comprised of two separate, fabricated 
ventricles and features adjustable ventricular orientation. Each ventricular device is 
comprised of a multi-layer urethane shell with the internal volume separated by an 
elastomer diaphragm. One side of the device’s partition is confluent with an extracorporeal 
pneumatic driver via conduits. The opposite side of the partition is confluent with the 
patient’s blood and cardiovascular circuit. The pneumatic driver engages with the partition 
via a dynamic pressure gradient. During systole, the driver increases pneumatic pressure 
by deforming the diaphragm and decreasing available volume for the blood. A one way 
valve connected to the inflow closes, forcing blood through the outflow tract and into the 
body. During diastole, the pneumatic driver ceases, and pressure in the blood volume 
overcomes the pressure in the air partition. The outflow valve closes and the inflow valve 
opens forcing blood to enter the ventricular device. This process enables the device to 
partially fill at a fixed percentage to simulate a heart stroke. The entire process is illustrated 
in Figure 19 [20]. 
In some adolescent and small adult patients with advanced, biventricular heart 
failure awaiting transplant, the TAH has been utilized as an assist device [48]. The TAH 
was chosen for these higher risk patients as the device has demonstrated a reduced 
incidence of stroke and transient ischemic attacks [20], [48]. Unfortunately, the 
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deployment of the TAH in pediatrics and undersized adults is limited. Of the 1,061 patients 
placed on the TAH, only 21 (2%) were under the age of 18 years of age9. The limitation is 
largely due to the adult-oriented size of the device and its poor capabilities of gross fit in a 
smaller thoracic chest. Device performance or patient viability may be adversely affected 
by thoracic impingement or other fit complications. 
For proper fit and function, the recommended minimum body surface area (BSA) 
is 1.7 m2 and the anteroposterior (AP) distance between the sternum and spine at the level 
of T10 is 10 cm [48]. These criteria represent a significant barrier for TAH in the pediatric 
and small adult population. In addition, there are few certified pediatric centers with the 
experience of implanting a TAH in children. The needs for device modification to 
accommodate complex congenital anatomies for children, small adults, or adults with 
structural anomalies constricting available thoracic space remain challenges to deploying 
the TAH in pediatrics in this current era [21]. 
 
9 The number of patients placed on the 70cc TAH was accurate as of December 13, 2013 when provided by 
SynCardia Systems Inc. 
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 Figure 19: The cardiac cycle of the TAH operates by transporting 
pressurized air in and out of the pneumatic chambers of the left and right 
ventricles in synchronization through the attached percutaneous drivelines 
connected to the external pneumatic driver. A and B illustrate the systole 
analogue heart stroke. C and D illustrate the diastole analogue heart stroke. 
 
The eligibility criteria has been established through analysis of cadaveric surgeries 
and anatomical metrics of the normal adult population10. That is, the criteria is intended to 
be representative of a majority of the normalized population, disregarding anatomical 
anomalies and outliers such as patients with congenital diseases or skeletal deformities. For 
smaller patients and patients with abnormal thoracic dimensions, the population-based 
metric may be ineffective in describing the potential fit of a device. The current criteria 
with its lack of specificity will have three possible outcomes with regards to true patient 
10 The description regarding establishment of eligibility criteria was provided by SynCardia Systems. 
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eligibility. The first outcome (1) is that the current criteria is sufficient in describing a 
patient’s eligibility, where adequate or inadequate dimensions (true positives and true 
negatives) are identified and treated accordingly. The second outcome (2) is a false positive 
where the criteria suggests good fit of the device, but poor fit would occur in the operating 
room. This may be caused by unusual thoracic conditions such as pectus excavatum 
creating further barriers to fit. The last outcome (3) is a false negative where failure to meet 
criteria results in patients rejection; however, a device would have actually fit without 
significant complications. For example, a patient with DCM, where cardiac anatomy is 
enlarged to near-adult size, may allow placement of an adult-sized device, is an example 
of a false negative. 
 The potential for false positives and false negatives is tied to the relatively patient-
agnostic eligibility criteria. By leveraging the latest in image processing and 3D 
visualization, the sensitivity (probability of a true positive) and specificity (probability of 
a true negative) can be increased. Image processing and 3D visualization enables patient 
specific data to be compared to manufacturing specifications for a more detailed analysis 
regarding fit. In addition, the novel methods – described as “virtual surgery” – enable 
further integration of the clinician’s experience into the fit analysis. Thus, a mechanism for 
surgical planning is enhanced with prediction and mitigation of complications. Virtual 
surgery, as its name implies, allows a clinician to approach fit analysis in the same manner 
as approaching the surgery itself. With regards to TAH virtual surgery, the clinician 
virtually resects ventricles, places device, optimizes device orientation, closes the virtual 
sternum, and looks gross device fit. The methods, evaluations on virtual sensitivity and 
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Cardiothoracic surgery teams at participating institutions identified 29 patients in advanced 
heart failure. Each institution recognized the 70cc TAH as a potential candidate for 
palliation and bridge-to-transplantation. While established eligibility criteria suggested 10 
cm at T10 (measured sternum-to-spine) and 1.7 m2 for BSA, 11 patients (37.9% of possible 
candidates) failed to meet at least one of those criteria. BSA values are not recorded at 
every institution, and several institutions failed to provide metrics (height and weight) to 
calculate BSA. T10 measurements were calculated for all patients; 10 patients (34.5% of 
possible candidates) failed to meet the T10 criteria. The novel virtual implantation 
procedure was implemented on all 29 patients including the under-sized patients. 
 
3.2.1 Image Acquisition and Reconstruction 
 
Per standard-of-care at the participating institutions, the patients received a CT scan. 
Unlike all image acquisitions for PHDMs, CT scans from the various institutions were less 
likely to have a contrast agent; only 62.1% of the participating cases (18 patients) had a 
contrast-enhanced CT. 
Imaging protocols were not homogenized over the participating institutions as the 
imaging was part of standard-of-care. Spatial resolution of the CT datasets varied from 
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patient-to-patient and institution-to-institution. Slice thickness (resolution in z-direction) 
commonly ranged from 0.325mm to 0.9mm; pixel spacing (resolution in x- and y-
direction) ranged from 0.325mm to 0.625mm. The resulting images were packaged into 
DICOM files. Per HIPAA standards, data were anonymized prior to transmission to the 
data coordinating institution. 
The DICOM files were imported into Mimics Innovation Suite. While the software 
facilitated image segmentation, skeletal structures and airways were segmented for every 
patient dataset. For datasets acquired with contrast-enhancement, cardiac anatomy subsets 
were segmented: left atrium (including pulmonary veins), right atrium (including vena 
cava), left ventricle, right ventricle, pulmonary arteries, aorta, and coronary arteries. The 
segmented masks were reconstructed into 3D surface mesh models. Computational cardiac 
anatomies were differentiated via the previously defined (Table 1) standardized color 
scheme as seen in Figure 20A. 
For non-contrast CT datasets, cardiovascular anatomy could not be segmented from 
surrounding soft tissue. The lack of segmentation for reconstruction would make 
subsequent processes difficult. To overcome the lack of anatomical information. Target 
discs were created and placed in the approximate position of the 4 native heart valves as 
seen in Figure 20B. 
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 Figure 20: A) Reconstruction of heart failure anatomy from a contrast-
enhanced CT dataset. B) The reconstruction from a CT with insufficient 
contrast. A target disk was used to approximate location of the tricuspid 
valve. 
   
3.2.2 Surface Mesh Generation of MCS Devices 
 
 A 70cc TAH device was laser scanned in order to obtain a surface mesh model. The 
laser scan utilized passive sensor and image-based modeling technology leveraging 
photogrammetry. A 2D grid was projected onto the surface of the TAH device while 
cameras recorded the 3D distortion of the projected grid. Image processing techniques 
permitted the development of a surface mesh from shape information grid curvature  [49]. 
 The data was imported into Geomagic where a surface mesh was generated from 
the point cloud data. Geometric holes or data aberrations were removed. Device volume 
and surface area was compared to experimental values provided by SynCardia Systems. 
The laser scan data was exported as a stereolithography file (.stl), a format that contains 
surface mesh information. 
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3.2.3 Virtual Implantation 
 
Anatomical reconstructions were imported back into Mimics and re-registered to the axial, 
sagittal, and coronal medical images. The process proceeded as a virtual analogue of the 
actual TAH surgery. The computational models of the ventricles were excised and the 
computational 70cc TAH models were imported and implanted. The inflow of the right 
device was placed adjacent to the right atrium and the tricuspid valve, while the outflow 
was placed next to the pulmonary trunk and pulmonary valve. The inflow of the left device 
was placed adjacent to the left atrium and mitral valve, while the outflow was placed next 
to the aortic root and aortic valve. The two device lobes, while constraining the inflow and 
outflow locations, were moved closer together and posterior to the sternum, where possible. 
A cardiothoracic surgeon guided the placement and optimization of the TAH and verified 
the realistic implantation (given the available data); a virtual implantation can be seen in 
Figure 21A. An outline of the device was projected on the 2D CT slices in order to correlate 
virtual model location to patient anatomy as seen in Figure 21B. 
 The surgeon examined the virtual implantation, using both quantitative and 
qualitative metrics, to determine fit. Quantitative metrics include measured TAH overlap 
on the thoracic skeleton, great vessels, airways, and diaphragm. Overlap between virtual 
TAH device and anatomy observed in images would imply displacement or impingement 
of patient anatomy. The cardiothoracic surgeon gave his observations on the virtual fit and 
the potential implications on an actual surgery. 
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 Figure 21: A) Virtual implantation of the 70cc TAH. B) Contour overlays 
illustrating the relationship be of the virtual implanted TAH and the current 
cardiovascular anatomy. 
 
 The results of the virtual procedure were sent to originating institutions in the form 
of videos illustrating implantation and a text summary by the collaborating surgeon. No 
attempt was made to supersede the existing eligibility criteria; the virtual implantation 
information only supplemented the current fit scheme.  
 
3.2.4 Hybrid Technology Acceptance Study 
 
Due to the uncontrolled protocols of the 20 participating clinical institutions, a clinical trial 
with homogenized inclusion/exclusion, imaging protocols, and outcome metrics was not 
feasible. A technology acceptance study was established in its place to determine feasibility 
and potential adoption for a clinical trial. 
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The following information was requested from the participating institutions: 
1. What did your institution record as the T10 measurement? 
2. What did your institution record as the BSA? 
3. What is the patient’s age and sex? 
4. What was/were the main cardiovascular defect(s)? 
5. Did you find the virtual implantation helpful in assessing MCS device 
fit or potential complications? 
6. Was the 70cc TAH implanted? 
7. If “No” to #6, were potential fit complications the main concern? 
8. If “Yes” to #6, were there any fit-related complications? 
9. Would you choose to exercise virtual fit analyses prior to future MCS 
surgeries if the option were available to your institution? 
10. Do you have any feedback that will make this technology more useful 
to you or your institution in the future? 
 
3.3 Virtual Implantation Case Studies 
 
Two case studies illustrate the virtual implantation through 1) a retrospective implantation 
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3.3.1 MCS Implantation Case Study – Retrospective 
 
A case study succinctly illustrates the current eligibility criteria deficits and the early 
development of the virtual implantation technique. A 14-year-old male presented with 3-
week history of cough, shortness of breath, upper respiratory tract symptoms, and fever. 
An echocardiogram revealed biventricular dysfunction with an ejection fraction of 15-
17%; an ejection fraction less than 40% is considered reduced [10]. Multiple clots were 
present in the left ventricle and left ventricular outflow tract. The patient was diagnosed as 
having dilated cardiomyopathy, severe biventricular dysfunction, and ventricular 
arrhythmias. Advanced heart failure medical optimization was initiated with intravenous 
inotropic support. 
The patient acutely decompensated and was placed on extracorporeal life support 
(ECLS) as a means for short-term medical optimization. He was accepted for heart 
transplantation and placed on the Status 1-A waiting list (the most urgent classification for 
the waiting list). After 8 days of ECLS support without a donor becoming available, the 
decision was made to transition to an MCS device. 
The medical team chose to deploy a 70cc TAH as a bridge-to-transplantation. The 
patient failed to meet the recommended fit criteria for the TAH: BSA greater than 1.7 m2 
and an anterior-posterior (AP) distance of the thoracic cavity measured at T10 to be greater 
than 10 cm. The patient’s BSA was 1.5 m2 with AP distance at T10 was 9.8 cm. A 
preoperative chest CT scan assisted in the final determination to proceed with TAH- 
implantation. 
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A median sternotomy was performed to open the chest. The width of the 
pericardium and distance from the anterior of the spine to the posterior table of the sternum 
were measured and the dimensions confirmed image findings. Despite the undersized 
thoracic space, the clinicians believed there to be adequate space for the TAH. The decision 
was made to continue the TAH implantation. The ventricles and all native heart valves 
were excised, and the TAH was implanted without incident. A transesophageal 
echocardiogram confirmed successful implantation of the TAH and showed no 
impingement of the left and right atrium. 
The sternum was closed on postoperative day 1. During closure, the left 
pericardium was opened and the TAH was shifted to the left pleural space to reduce 
pulmonary vein impingement, as evidenced on echocardiography. A study by LePrince et 
al. suggests this technique to be useful in small patients with a BSA between 1.5 and 1.6 
m2 [48]. Echocardiogram at the time of chest closure revealed unobstructed systemic and 
pulmonary venous return. 
The patient had no major hemodynamic events such as bleeding or stroke. 
Postoperative care was complicated by an opacification of the left lung, seen on the chest 
x-ray (CXR) on post-operative day 1. Clinicians feared that the device was impinging on 
structures unobserved in the echocardiogram. Contrast-enhanced CT was acquired of the 
thoracic cavity and confirmed the respiratory findings of the CXR. To analyze possible 
obstruction of pulmonary vasculature and bronchi, 3D reconstruction was performed. 
Image processing via segmentation rendered the 2D slice data into 3D computational 
models. Cardiovascular, respiratory and skeletal (including costal cartilage) structures 
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were segmented from the CT, using Mimics. These segmented masks were reconstructed 
into 3D surface mesh models and imported into 3D modeling software. 
Since the TAH device is manufactured with a radio-transparent urethane, the 
exterior surface of the device does not show up on CT images. Only the internal air and 
blood volume of the device can be detected. To obtain a clear spatial relationship of the 
device to surrounding tissues, a geometric representation of the device’s surface was 
needed. The computational model of the laser-scanned TAH was imported into the 3D 
modeling software alongside the patient’s anatomical reconstruction. The surface mesh of 
the TAH was aligned to its segmented lumen from the CT reconstruction. The combination 
of patient data and scanned data provided an inclusive and accurate view of the TAH’s 
impact on the surrounding anatomy. The virtual 3D model demonstrated no compression 
of the pulmonary veins by the device. The 3D reconstruction confirmed that the size and 
location of the TAH were not constricting factors for the cardiovascular or respiratory 
structures. The decision was made to not re-open the patient’s chest. 
The left lung was found to be atelectatic (filled with fluid) and improved with 
aggressive recruitment maneuvers. A bronchoscopy revealed some mucus plugs found in 
the left bronchial tree that were suctioned. The patient was extubated successfully on 
postoperative day 6. Following extubation, the patient was able to quickly advance in his 
diet and ambulate throughout the hospital. The patient was supported with the TAH for 11 
days prior to successful heart transplantation. 
This case study confirms that the TAH can be successfully deployed in selected 
pediatric patients who have a smaller BSA than 1.7 m2. This patient’s postoperative course 
was complicated by left lung atelectasis. A chest CT with 3D reconstruction was crucial in 
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visualizing the pulmonary arteries and veins and bronchial structures to rule out 
compression from the device. The success of utilizing CT with segmentation and 3D 
modeling, as seen in this case study, demonstrates the potential for patient-specific device 
fit analysis. A study by Dowling, et al. acknowledged CT with 3D reconstruction as a 
powerful tool in predicting appropriate fit of any potential candidate who was considered 
for implantation of the AbioCor Implantable Replacement Heart System [51]. SynCardia 
has recently manufactured a new 50 cc TAH that has received a Humanitarian Device 
Designation for pediatric bridge-to-transplantation by the FDA. As development and 
testing of this new technology progresses, its future deployment and utilization will 
broaden pediatric application of TAH. In fact, the following case study builds on the work 
discussed here. A virtual implantation comparison between a 70cc and 50cc TAH was 
developed in an emergent scenario. 
 
3.3.2 MCS Implantation Case Study – 70cc vs 50cc 
 
A 53-year-old female in advanced heart failure was initiated with intravenous inotropic 
support for medical optimization. The decision was made to transition to a 70cc TAH as a 
bridge-to-transplantation. The patient failed to meet the recommended fit criteria for the 
TAH; the patient’s AP distance at T10 was 9 cm. Following the implantation, surgeons 
were unsuccessful in closing the sternum. The surgeons left the chest open hoping that 
trama-induced swelling would reduce over time; this reflects other literature delayed 
closure for TAH implantation [48]. In following days, the sternum would still not close. 
Surgeons requested virtual implantation of the 70cc TAH from a pre-operative CT scan. 
  81 
 3D reconstruction was performed. Image processing via segmentation rendered the 
3D computational models of the anatomy. Cardiovascular, respiratory and skeletal 
(including costal cartilage) structures were segmented from the CT. These segmented 
masks were reconstructed into 3D surface mesh models and imported into 3D modeling 
software. Virtual implantation of the 70cc TAH revealed high potential for thoracic wall 
impingement in addition to less-than-ideal orientation of the inflow and outflow cuffs; this 
orientation complication can result in obstruction of pulmonary vessels further affecting 
pulmonary blood pressure. At the request of SynCardia Systems, the 50cc TAH was 
virtually implanted in the same dataset. 
In addition to the methods presented in the section 3.2.2, a surface mesh model of 
the 50cc TAH needed to be constructed. For the 50cc TAH, SynCardia Systems provided 
a solid (computer-aided design or CAD) mesh model. The CAD drawings had to be 
parameterized and tessellated to a surface mesh representation. The surface mesh data was 
exported as a stereolithography file. 
Following the optimized placement of the smaller MCS device, thoracic wall 
impingement was eliminated while complications in orientation were considerably 
reduced, although not eliminated. The results of the orientation were shared with the 
clinical institution, and the decision to transfer the patient to the 50cc TAH was made. 
 Surgeons disconnected the synthetic cuffs of the 70cc TAH, removed the device, 
and inserted the 50cc TAH.  Following standard procedure, the cuffs were reconnected to 
the smaller TAH. Following the operation, the patient’s sternum was successfully closed. 
Echocardiogram revealed ideal pulmonary blood flow and pressures. Since closure, the 
patient had no major hemodynamic events such as bleeding or stroke. Not only does this 
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case study illustrate the potential of virtual implantation to avoid fit-related complications, 




3.4.1 Results of the Virtual Implantations 
 
Twenty-nine patients were identified as potential candidates for the 70cc TAH. Ages 
ranged from 10-67 years with BSA ranging from 1.19 - 2.29 m2 (from available 
information). These patients underwent virtual implantation. From the 11 patients that 
failed at least one of the tradition eligibility criteria, 4 patients (36.4%) were determined to 
be a possible fit according to the cardiothoracic surgeon utilizing the virtual implantation. 
These patients represent a potential false negative rate (with regards to the current 
eligibility criteria) at 13.8%. Furthermore, of the 18 patients that passed T10 eligibility 
criteria, 3 patients (16.7%) were deemed an “ill-fit” according to the cardiothoracic 
surgeon. These patients represent a potential false positive rate (with regards to the current 
eligibility criteria) at 10.3%. A complete list of patients, eligibility criteria, and virtual 
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Table 14: Results from virtual implantation.  Failure with regards to 
traditional eligibility criteria are highlighted in light red. Instances where 
traditional eligibility criteria does not pass fit, but virtual implantations 
illustrates potential fit are denoted as a false negative (F.N.). Instances 
where traditional eligibility criteria passes fit, but virtual implantations 
illustrates potential complications are denoted as a false positive (F.P.). 
Instances where institutions withheld information is identified as “not 
provided” (N.P.). Yes* refers to cases where the 50cc TAH was approved, 
but the 70cc TAH was rejected. 
 
Pt  Sex Age 
(yrs) 















1 Male 14 USA 9.0 1.56 Yes No F.N. 
2 Female 12 USA 9.8 1.42 No No  
3 Female 14 USA 9.5 1.75 Yes No F.N. 
4 Male 14 USA 7.5 2.06 Yes No F.N. 
5 Male 16 USA 10 N.P. Yes No  
6 Male 14 USA 13 2.29 Yes No  
7 Female 16 USA 9.8 1.19 No No  
8 Male 45 USA 11 N.P. Yes No  
9 Female 26 USA 10.09 1.62 No No  
10 Female 19 USA 10 N.P. No No F.P. 
11 Male 17 USA 10.5 N.P. Yes No  
12 Male 67 Croatia 12.7 N.P. Yes Yes  
13 Female 36 Croatia 8.9 N.P. No No  
14 Male 32 Czech Republic 15 1.76 Yes No  
15 Female 46 UK 9.2 N.P. Yes No F.N. 
16 Male 30 UK 15 2.16 Yes Yes  
17 Male 43 USA 12.5 1.758 Yes Yes  
18 Male 53 Slovenia 10.5 N.P. Yes Yes  
19 Female 34 Slovenia 10.5 N.P. No No F.P. 
20 Male 61 USA 11 N.P. Yes No  
21 Male 16 USA 9.7 N.P. No No  
22 Male 52 Croatia 13.5 N.P. Yes No  
23 Male 48 Croatia 15 N.P. Yes No  
24 Female 16 USA 10.5 1.66 No No F.P. 
25 Female 19 France 8.5 N.P. Yes* Yes*  
26 Female 53 USA 10.9 N.P. Yes* Yes*  
27 Male 10 USA 8.5 N.P. No No  
28 Female 37 USA 11 2.1 Yes No  
29 Female 55 USA 12.5 N.P. Yes No  
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3.4.2 Results of the Hybrid Technology Acceptance Study 
 
The TAM survey was completed by 31.6% of participating institutions11. All respondents 
indicated that they would prefer using the virtual implantation procedure for MCS device 
fit analyses in the future. The breakdown of case and TAM is shown in Table 15. Only one 
institution provided extra feedback on the utility of the virtual implantation. In particular, 
they commented that there was not a sufficient technological framework for transmitting 
the medical images. However, the mechanism for medical image transmission was beyond 













11 The originating institution was not surveyed to mitigate potential biases.  
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Table 15: Results from virtual implantation technology acceptance study. 
Six out of the 19 participating institutions completed surveys; 100% of 
respondents said they would like to utilize virtual implantation processes in 
the future to in in MCS device fit prediction. Instances where institutions 
failed to respond to the survey are identified with “N.P.” (not provided). 
 
Pt  Country of 
Origin 








Would you utilize 
the process for 
future MCS cases? 
1 USA Fail Yes No  
2 USA Fail No No  
3 USA Fail Yes No  
4 USA Fail Yes No  
5 USA Pass No No  
6 USA Pass Yes No Yes 
7 USA Fail No No Yes 
8 USA Pass Yes No N.P. 
9 USA Fail No No Yes 
10 USA Pass No No N.P 
11 USA Pass Yes No N.P 
12 Croatia Pass Yes Yes N.P 
13 Croatia Fail No No Yes 
14 Czech Republic Pass Yes No N.P 
15 UK Fail Yes No N.P 
16 UK Pass Yes Yes N.P 
17 USA Pass Yes Yes Yes 
18 Slovenia Pass Yes Yes N.P 
19 Slovenia Pass No No N.P 
20 USA Pass Yes No N.P 
21 USA Fail No No N.P 
22 Croatia Pass Yes No N.P 
23 Croatia Pass Yes No N.P 
24 USA Pass No No  
25 France Fail Yes Yes Yes 
26 USA Pass Yes* Yes* N.P 
27 USA Fail No No N.P 
28 USA Pass No No N.P 
29 USA Pass No No N.P 
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3.5 Discussion and Conclusion 
 
The SynCardia 70cc TAH and other adult-orientated MCS devices have potential for 
pediatric and small adult heart failure populations. Case studies show that the TAH can fit 
in patients beneath the eligibility criteria without complications relating to fit (see Section 
3.3) [21]. A prospective fit analysis confirms the anecdotal implications of the undersized 
patient case studies. 
 If the false negative results of the study hold true for the larger population, we can 
present a theoretical vignette as to the unnecessary rejection of patients due to the current, 
restrictive criteria. A direct linear regression would illustrate that with a 10.3% false 
negative rate and the number of patients that have received a TAH (n=1,061), 
approximately 109 patients were theoretically and unnecessarily excluded for 
consideration of the TAH, since the device has been approved for use. This number would 
be further inflated when considering all patients that were considered for a device, but did 
not receive one. While the specific false negative rate is not statistically significant, the 
potential for additional patient inclusion is promising. Furthermore, with approximately 
400 hearts transplanted in pediatrics each year, additional MCS deployments could be life-
saving. 
 As a contra positive vignette, the false positive rate was found to be at 6.9%. Again, 
if the trends discuss here hold true for a larger population, there is the potential that 73 
patients, out of the 1,061 total, suffered fit complications. These complications may have 
needed follow up surgery, further risking the patient’s life, or may have resulted in in 
increased morbidity or mortality. However, this is speculative as the rates of these 
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complications are currently not well tracked. The STS is a small subset of American 
institutions and may not provide a thorough enough image to validate the potential 
complications related solely to fit. 
Immediate fit considerations include the closure of the patient’s chest following 
surgery. In cases where the chest could not be closed, a higher incidence of device 
malfunction, bleeding, infection, and death were observed [20], [48]. In addition to closure-
related complications, issues following anatomical impingement are predicted for 
undersized chest including respiratory complications and aberrant cardiovascular 
pressures. The virtual implantation provides a method for viewing the potential fit within 
the thoracic skeleton. This gross fit is the first step in determining patient viability for the 
TAH device. 
Beyond the rigid definitions of passing or failing the virtual fit, the virtual 
optimization process opens windows into patient care or complication mitigation. Results 
and surgeon observations of a virtual implantation for a 43 year old male with complex 
CHD consisted of a video illustrating fit in addition to text describing fit and potential 
complications: 
 
“Based on the reconstruction and virtual implantation, the 70cc TAH 
appears to fit within the current ventricular mass; however, there is no 
significant room for movement of the device due to the sternum and costal 
cartilage. Consideration will have to be made regarding the current 
placement of pacing leads prior to surgery. … Although the device appears 
to fit in the area of the ventricular mass, device orientation will likely be 
  88 
affected by the strategy utilized to manage the transposed great vessels, 
either maintaining the existing atrial level reconstruction (Mustard) and 
directing the outflow to the appropriate great vessel, or by restoring normal 
atrial configuration and directing outflow grafts to corresponding great 
vessel. … Consideration of retention of the atrial baffle with persistent 
superior limb obstruction should be made. If atrial baffle is not retained, the 
TAH may need to be moved in addition to the construction of unique baffle 
or arterial switch.” 
 
This institution that chose to proceed with 70cc TAH was provided with a wealth of 
information prior to a surgery. Some of the information, such as the atrial baffle, may 
require additional surgical devices. Knowing the potential for surgical complications, such 
as needing additional equipment or novel cut down procedures, may decrease surgical time 
as well as reduce complications related to surgeon making decisions in real-time in the 
operating room. A proper, protocol-controlled clinical trial will be needed to validate the 
assertions made regarding surgical planning. 
 These case series and limited quantitative analysis illustrates the potential utility, 
and applied utility, of the virtual implantation of the 70cc TAH. In fact, the same 
technology was applied to two other MCS devices during the course of this study. This 
study also illustrates concerning deficits in the current eligibility criteria. The lack of 
specificity and sensitivity suggests that 24.1% of the study’s cohort (6 out of the 29 
patients), without virtual implantation, would have received less-than-optimal fit planning 
by the current, patient-agnostic criteria alone. Lastly, the virtual implantation technique 
  89 
can help predict fit-related complications or, in the absence of better options, complications 
that may be mitigated by sufficient surgical planning. 
 The techniques explored in the virtual implantation of the TAH are not limited to 
the single MCS device. The same technique and procedure was applied to an undersized 
patient with the HeartWare (HeartWare International, Framingham, MA, USA) MCS 
device. In this case, the patient was far below the normal size recommendation and failed 
to pass virtual fit. 
 In addition to device fit, similar questions exist in heart transplantation regarding 
donor heart selection criteria. For instance, a cardiothoracic surgeon listing a pediatric 
patient on the heart transplantation donor list must specify the range of hearts the institution 
is willing to accept. The metrics for size of the donor heart are specified by the donor’s 
height and weight. It is perceived by collaborating cardiothoracic surgeons, that this current 
selection criteria is insufficient in patient-specific care. The surgeons must establish the 
largest acceptable donor population for the recipient while avoiding a heart that is too large 
or too small to function properly. In fact, the virtual heart transplantation procedure was 
carried out on a single patient so far due the perceived success of the virtual implantation 
of the TAH. In addition, other anatomical transplantations are being pursued for the virtual 
surgery. 
 
3.5.1 Implications of Technology Acceptance Study 
 
Besides the efficacy of the virtual implantation, it is critical to examine the 
perceived utility and ease-of-use of the novel tool. Without technology acceptance from 
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medical professions, the tool, no matter how capable, will not be adopted into use. For this 
study, the TAM was developed as a follow-up survey to the implantation results. In the 
domain of perceived usefulness, two questions (#5 and #8) probed the participants’ 
perception of the virtual implantation as an effective tool. All participants to the survey 
responded in the positive. The virtual implantation technology was “helpful in assessing 
MCS device fit or potential complications.” Where the collaborating surgeon suggest ill-
fit of the device, survey participants also responded in the affirmative that fit-related 
complications were a shared concern.  The open response question (#10) solicited feedback 
for future iterations of the virtual implantation tool; only one participant responded directly 
related to the technology: 
 
“Yes, we would do the virtual analysis in the future. The virtual 
implantation allows our surgeon to better prepare for the implantation and 
have a more educated and guided “idea” on how he will be placing the 
device. Moreover, it gives us some additional certainty that the device will 
actually fit.” 
 
The virtual implantation process appears to provide a useful tool to the clinical care team 
at recipient institutions. 
Due to the limited extra-curricular time for surgeons and surgeon support staff, the 
TAM survey was limited in order to promote compliance. Only one question addressed 
perceived ease-of-use (#9). All survey participants agreed that they would choose to 
exercise virtual fit analyses prior to MCS surgeries if the option was available. These 
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answers illustrate that the participants felt that the virtual tool was useful and non-invasive 
to the current planning process and would use it again in the future. The TAM survey as 





The virtual implantation technique here is largely qualitative in determining fit. Where 
some structures can be seen as binary metrics for fit, such as virtual overlapping of the 
sternum and the device, the soft tissue impingement must be considered by the surgeon. 
He or she will ultimately make the decision for implantation. Future iterations of this 
technology may deploy finite element modeling in conjunction with evidence-based 
medicine to more accurately predict potential device fit failure. For instance, the device 
implantation would displace the surrounding tissue causing surrounding structures to 
deform and possibly narrow. A narrowing of a great vessel to a certain eccentricity may 
become the new metric for TAH (or MCS) fit. This finite element analysis of device fit has 
its own limitations. Specifically, there is not yet established foundation for the mechanical 
properties of tissue based on medical images and anatomical structures. While these 
overlaps are measured, there is no evidence-based literature that supports acceptable 
amounts of anatomical impingement. Even if the correlation of mechanical structures to 
specific anatomical structures could be determined, current generation computational 
architectures and resources would not likely facilitate virtual implantation in an emergent 
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timeframe. Future computing capabilities and advanced simulation software may make this 
finite-element-based virtual implantation process a possibility. 
  
3.5.3 Concluding Remarks on Virtual Implantation 
 
To date, 29 virtual implantations12, spanning 10 states in the United States and 5 additional 
countries, have been performed with this technology. The virtual implantation process 
allows for a more precise selection of a medical device for a specific patient. The virtual 
implantation process may be capable of expanding the effective inclusion criteria, thus 
opening a MCS device to a wider potential patient population. At the same time, virtual 
implantation may help to reject patients who would otherwise result in fit-related and 
surgical complications. Despite its current limitations of the virtual implantation process, 
its utility as a clinical decision has been rapidly gaining acceptance, as illustrated by the 
TAM study; accordingly, the process has been translated to three additional MCS devices. 
  
12 This complete accounting of TAH virtual implantations includes the procedures discussed in the hybrid 
TAM study as well as cases preceding the establishment of the hybrid TAM protocols. 
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CHAPTER 4 
ANCILLARY WORK – SURGICAL SIMULATION 
 




Medical students and surgical residents develop medical and surgical knowledge through 
various media including lectures, textbooks, publications, and other content delivery 
mechanisms [52]. These learning mechanisms are vital to educational success; however, 
textbook knowledge does not necessarily translate to acquisition and mastery of procedural 
skills. Development of surgical skills toward mastery requires direct intervention on a 
patient, specialized educational environments (e.g., a cadaver lab) for and/or a patient 
simulator [52], [53]. 
The purpose of a simulator is to develop procedural knowledge. Procedural 
knowledge involves two main functions as defined by Kahol et al., which are cognitive and 
psychomotor functions [54]. An effective medical simulation enhances the learning of both 
behavioral functions [55], [56]. Simulacra, the physical, non-curricular components of 
simulators, replicate anatomies consistent with learned content knowledge, while the 
simulator’s curricula target the learner’s development of procedural skills. Learners are 
often compelled to reconcile content knowledge with procedural knowledge [57]. Through 
the use of a simulator, learners progress toward mastery of surgical skills outside of the 
risk-inherent environment of an operating room [57]–[59]. The learner is free to focus on 
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the development of cognitive and psychomotor skills without the risk of catastrophic 
consequences. Simulation in this context is a method of cognitive training that has been 
thoroughly validated [58], [60]–[63].  
Educators can leverage the strengths of medical simulators to effectively teach 
complex and high-risk surgical procedures, such as placement of an external ventricular 
drain (EVD). This procedure is used to monitor intracranial pressure (e.g., in trauma 
patients or patients presenting with a Glasgow coma scale of 3-8 or less [64]) or to treat 
symptoms of hydrocephalus (such as patients with decreased cerebrospinal fluid (CSF) 
absorption due to subarachnoid hemorrhage or ventriculitis or patients with CSF pathway 
obstruction due to tumors, cerebral hemorrhages, etc.)[65]. CSF release is recommended 
in patients with SAH grade II or higher according to American Heart 
Association/American Stroke Association [66]. These sources of increased ventricular 
pressure, and the subsequent need for that pressure to be alleviated, presents a need for 
surgeon mastery of the ventriculostomy procedure. In fact, placement of an EVD 
constitutes one of the first bedside procedures learned in residency training and one of the 
most common procedures performed in the neurosurgical field [67], [68]. To improve 
neurosurgery education capabilities, the authors developed a ventriculostomy simulator 
leveraging the latest in rapid prototyping technologies in conjunction with traditional 
casting techniques (both elastomer and hydrogel). Virtual or mixed simulators for 
ventriculostomies have been developed previously [67], [70]; however, the prior computer-
based simulators had high associated costs in terms of both equipment and facilitators. We 
describe the development of a cost-effective physical simulator for ventriculostomy 
placement. The goal of the proposed simulacrum is to facilitate medical simulation by 
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teaching three cognitive tasks: 1) develop an understanding of the geometry associated to 
the cranium and its landmarks in relation to the frontal horn of the lateral ventricles, 2) 
develop an awareness of the common ventriculostomy field of view, and 3) gain familiarity 
with the instruments and the methods used in deploying a ventricular cannula. The 
simulacrum features the integration of patient-derived cranium, brain, and lateral 
ventricular spaces. A simplified gravity-driven pump generates a constant ventricular 
pressure based on facilitator demands. The material choices for each component provide 
appropriate turgor and recoil to adequately simulate the surgical experience according to a 
limited qualitative study. The educational study also serves to establish potential efficacy 
of the model according to a technology acceptance model (TAM)[25]. The model is an 
attempt to quantify perceived usefulness and perceived ease-of-use of a new technology. 
Without the perception of efficacy, the simulator would fail to be adopted into standard 
educational practice. The techniques for developing the model, the educational study, and 
the associate advantages and disadvantages are discussed. 
 
4.1.2 Methods – Computational Modeling 
 
The initial computational model for the simulacrum was derived from two datasets. Head 
MRI data were acquired with 1.5mm slice thickness and 0.488mm pixel spacing in images 
of 512x512 pixels. Skull CT data were acquired with 0.625mm slice thickness and 
0.488mm pixel spacing in images of 512x512 pixels. The resulting images were packaged 
into two Digital Imaging and Communication in Medicine (DICOM) files and imported 
into Mimics (Materialise, Lueven, Belgium), a medical image processing software suite. 
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The software facilitated image segmentation, the process of separating regions of an image 
into discrete subsets. Three subsets resulted from segmentation: brain, skull, and lateral 
ventricles. These masks were reconstructed into three-dimensional (3D) surface mesh 
models. Skull and cerebral models were then imported into an engineering software suite, 
Geomagic (3DSystems, Rock Hill, SC, USA). 
The inferior third of the skull was removed to reduce simulator costs, and the 
posterior aspect of the skull was removed to create an opening for the installation and 
removal of the brain model. Two windows were cut from the superior aspect of the skull 
to allow the interchanging of disposable bone plates for burr-hole placements, allowing 
multiple attempts during simulation. The brain model was truncated at the same position 
as the skull model. Undercuts created by deep sulci were removed to prevent issues with 
molding and casting. The lateral ventricles were also truncated, and a back plate was added 
to the ventricular system to facilitate molding and casting. The computational models of 
the brain with ventricles and truncated skull are shown in Figure 22. 
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 Figure 22: a) Rendering of the brain following MRI reconstruction. The 
lateral ventricles are highlighted in light blue. The anterior horn of the 
lateral ventricle rendered in dark blue is used in the final physical model. b) 
The skull has been truncated to increase durability of the model in addition 
to cost savings. 
 
4.1.3 Methods – Physical Modeling 
 
The adjusted skull model was printed using a zPrinter 650 (3Dsystems, Rock Hill, South 
Carolina, USA) with 0.1 mm layer thickness. This additive manufacturing process prints a 
cyanoacrylate binding agent onto a gypsum-powder medium, creating a final material 
similar to bonded plaster. Tactile qualities of the composite material are similar to those of 
actual bone, especially when handled with surgical instruments (e.g., a manual twist drill). 
Additional bone windows as described in the preceding section were also printed as shown 
in Figure 2a. A Stratasys Dimension 1200es (Eden Prairie, Minnesota, USA) was used to 
print the final brain and ventricle models in an acrylonitrile butadiene styrene (ABS) plastic 
medium with a layer thickness of 0.254mm. This additive process heats a plastic spindle 
and extrudes it onto a platform, depositing material as a single layer. The process is 
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repeated layer-by-layer until the model is complete. Support material is removed in a 
heated, caustic (sodium hydroxide) bath. For the brain and ventricle prints, the plastic 
surface underwent selective chemical dissolution with a 90:10 by volume solution of 
xylene and acetone, respectively. The models were submerged in a secondary bath of 
isopropyl alcohol (91% by volume) to preserve optimal surface quality. Optimal quality is 
defined as removal of all visible striations inherent to additive manufacturing processes. 
A silicone spray release agent (Ease Release 20, Smooth-On, Easton, Pennsylvania, 
USA) was used to coat the plastic brain model. The plastic brain component was then 
placed inside a mold box and covered with a temperature resistant casting silicone 
(MoldMax 60, Smooth-On, Easton, Pennsylvania, USA). This process was repeated with 
the ventricles. Once cured, plastic components were removed from the silicone molds. A 
silicone cast was then created in the ventricular mold to generate the two elastomeric 
ventricular cores as seen in Figure 23b.  
A mixture of gelatin and agar gel powder (90:10 by weight) was added to distilled 
water (at 75°C) to achieve the desired gel concentration (1.2% by weight). The solution 
was stirred until homogenous and allowed to cool to room temperature. The gel was then 
placed in a 65°C water bath for an hour and returned to room temperature before another 
round of heating ensured hydration of the hydrogel powder. 
The brain mold and ventricle casts were coated with common cooking oil as a 
release agent. The heated gelatin/agar solution was poured into the brain silicone mold. 
The ventricle cores were inserted into molten medium, and the gel was cooled to room 
temperature. The brain was extracted from the mold prior to ventricular core removal. The 
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brain model, shown in Figure 23d was placed into the skull model to complete the proposed 
ventricular simulacrum as shown in in Figure 23a. 
 
Figure 23: a) Assembled simulator including printed skull and casted brain. 
The smaller pieces flanking the simulator are replaceable plates providing 
undamaged sites to each learner for the burr hole drilling component of a 
ventriculostomy. b) Silicone core-castA simple gravity-driven pump was 
created to build pressure within the ventricular system. A water reservoir 
delivered CSF analogue (water) to the ventricles at a constant pressure as 
determined by the simulator facilitator. A syringe in the drive line allowed 
simulator facilitators to manually increase ventricular pressure or create 
unsteady conditions as necessary for a given curriculum. An illustration of 
the simulator set-up is shown in Figure 24. 
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 Figure 24: Schematic drawing of the entire simulacrum. The cranium is 
rendered transparent to show placement of the brain and ventricles. R.T. is 
reservoir tank, C.S.F.a is cerebrospinal fluid analogue, F.C. is flow control 
syringe, Va is valve, and Sim is simulacrum. 
 
4.1.4 Methods – Educational and Technology Acceptance Study  
 
The assembled model was trialed by a group of medical students and residents (n=10) to 
qualitatively determine the simulator’s efficacy and establish the foundation for a future 
multi-cohort educational study. A 4th year post-graduate neurosurgery resident served as 
the facilitator for this study. A short curriculum based on standard practices used to 
complete a ventriculostomy was presented to the students. The ventriculostomy procedure 
started with drilling of a burr hole at Kocher’s point, approximately 10 cm posterior to the 
glabella, a landmark included on the simulator, and 2.5 cm lateral to the midline. Manual 
twist drill was used to create the burr hole, and the blunt end of the tunneling trocar was 
used to clear away any bone-analogue chips from the burr hole. A standard ventricular 
catheter was advanced into the burr hole and brain at an appropriate angle using anatomical 
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landmarks as guides. The ventricular catheter was advanced approximately 6.5-7cm to the 
edge of the bone. Placement success was determined by the presence of CSF analog fluid 
flowing from the ventricular catheter after stylet removal. An observer recorded the number 
of passes through the brain needed to obtain CSF flow. 
Prior to surgical simulation and curricula deployment, students completed a pre-
assessment questionnaire evaluating student familiarity with the ventriculostomy 
procedure. Following simulation, students completed a post-assessment survey with the 
same questions as the pre-assessment questionnaire. The latter survey included an 
additional 20 questions based on an expanded TAM model by Davis et. al. and Dabholkar 
and Bagozzi[25], [26]. Domains in this modified TAM include awareness/presence, 
perceived usefulness, perceived ease-of-use, enjoyment, attitude, and intention-to-use. The 
standard five-point Likert-scale was used to qualify responses (1 being strongly negative 




The simulator was used by 10 individuals with varying degrees of expert level. Medical 
students (n=4) and residents (n=6) from 0-5 post-graduate years (PGY) utilized the 
simulator. Five out of the six residents completed the simulation on the first attempt; all 
medical students and one 2-PGY resident needed multiple attempts to place the catheter 
into the ventricle. A comprehensive breakdown of all questions and responses related to 
the technology acceptance component of the survey is included in Table 16. All responses 
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gauged the perceived educational efficacy (as defined by the domains in the TAM) with 
means greater than “neutral” (3 on the deployed Likert-scale).  
Table 16 (next page): TAM post-assessment responses. TAM post-
assessment rating coded on a Likert scale: 1, strongly disagree; 2, disagree; 
3, neutral; 4, agree; 5, strongly agree. Means 4.0 and higher are color-coded 
as green, otherwise coded as yellow. Standard deviations 1.0 and lower are 
color-coded as green, otherwise coded as yellow. No statistical significance 
was determined. 
Technology Acceptance Questions (n=10) Score 
 mean ± std. dev. 
Awareness/Presence    
The tactile response of the bone helps me understand how far to drill. 3.7 ± 1.0 
The tactile response of the brain media helps me understand if the 
catheter is in the ventricle 
3.8 ± 0.9 
The cranial field of view helps me practice for a realistic intervention. 4.0 ± 0.8 
The patient derived model helps me appreciate anatomical landmarks. 3.9 ± 0.8 
Perceived Usefulness    
The simulator improved my performance of a ventriculostomy. 4.1 ± 0.7 
The simulator improved my understanding of the relationship of the 
ventricles to the cranium. 
4.0 ± 0.8 
The simulator has increased my confidence in performing a 
ventriculostomy in a patient. 
4.0 ± 0.8 
What I have learned in the simulator will impacted patient care. 4.0 ± 0.8 
The simulator was an effective use of my time. 4.2 ± 0.8 
Perceived Ease-of-Use    
The simulator was not cumbersome or difficult to interact with 4.1 ± 0.9 
This low cost simulator was well-designed. 4.3 ± 0.7 
The simulation did not take an unnecessary amount of time to complete. 4.4 ± 0.9 
The simulator was effective with some instruction. 4.7 ± 0.5 
The simulator would be effective without any instruction. 3.7 ± 0.9 
Enjoyment    
I enjoyed this simulator as an educational tool. 4.3 ± 0.8 
I enjoyed this simulator regardless of the potential educational value. 4.1 ± 1.1 
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Technology Acceptance Questions (n=10) Score 
 mean ± std. dev. 
Attitude    
The simulator will improve my surgical skills if given time to practice. 4.3 ± 1.0 
I have a positive attitude about this simulator. 4.6 ± 0.6 
Intention-to-Use    
The simulator encourages me to practice this medical intervention. 4.1 ± 1.0 
I wish simulators like this were created for other common procedures.  4.4 ± 0.7 




There are three basic approaches to medical simulation development: 1) cadaveric tissue 
models (human or animal), 2) computer-based or virtual reality systems, and 3) synthetic 
physical models. Each of these approaches has been employed in neurosurgical simulation, 
and each has its own advantages and disadvantages. For example, cadaveric dissection is 
well-accepted and introduces students and residents to surgical education early in clinical 
training [52], [71]. The cost of cadavers and the necessary facilities to preserve, 
accommodate, and maintain the specimens, however, is increasingly cost-prohibitive [72]. 
In addition, cadaveric models can lack the anatomical accuracy reflected in living patients. 
For example, a cadaver will not be able to illustrate the real-time scenario of increased 
ventricular pressure. One method to circumvent these limiting factors of cost, availability, 
and ability to simulate real-time pathology is to construct medical simulators. We believe 
the proposed model has great potential to provide a low cost and effective method of 
training residents in the following skills: 1) understanding of cranial geometry and its 
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landmarks in relation to the frontal horn of the lateral ventricles, 2) recognition of the 
appropriate entry point for ventriculostomy catheter placement, and 3) acquisition of 
familiarity with the instruments (e.g., manual twist drill, catheters, trocar, etc.) and the 
methods used in deploying a ventricular catheter. However, inherent to any simulator 
(physical or virtual) are simplifications of anatomy and physiology. 
The proposed simulacrum utilizes advanced rapid prototyping technologies and 
casting techniques to produce an effective surgical simulator. The simulacrum includes 
structures that simulate a realistic surgical field. The brain, lateral ventricular system, and 
skull are all of accurate anatomical scale, given that they are derived from patient data. 
Ventricular anatomy can be easily manipulated to represent abnormal anatomy if desired 
(e.g., displacement by a hemorrhage or tumor), since the mold pieces are separated in the 
casting process (brain parenchyma from ventricles); this compartmentalization in design 
imparts modular capability to the simulator. Ventricular geometries can be extracted from 
different patient datasets, reconstructed as 3D geometries, and then printed in a format 
compatible with the casting methods. A facilitator could have multiple malformed 
ventricular geometries, simulating a progression of disease or differences among diseased 
morphologies. 
Rapid prototyping has been broadly applied in the medical community [24], [73]. 
Early applications in generating cerebroventricular simulacra include Bova et al. where the 
modeling of the cranium employed additive manufacturing technology, but the ventricular 
systems was represented using a computer-generated haptic-feedback system [74]. These 
early models, while achieving a high level of anatomical complexity, were costly given 
they are “mixed-simulators” that contain elements of physical modeling as well as virtual, 
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haptic systems. The systems developed by Bova et al. included an electromagnetic tracking 
system. Our model achieves anatomical accuracy through 3D printing while maintaining 
low costs with readily available materials. Once initial molds have been created, final brain 
casts are produced using common and accessible materials. As of the publication date, 
material costs were approximately $4 per brain model. 
Regardless of cost, a simulator can only be considered effective if it facilitates 
development of cognitive and psychomotor skills. The proposed simulacrum demonstrated 
utility in conveying the location of the ventricle with respect to anatomical landmarks on 
the cranium, as evidenced by the pilot educational study. For example, following the 
insertion of the catheter, the learner is charged with locating the ventricle. 80% of the 
neurosurgery residents completed a successful ventriculostomy on the first attempt, while 
all medical students needed multiple attempts to succeed in catheter placement. This result 
suggests that increased surgical experience (it is assumed a resident has more years of 
experience than a medical student) results in a stronger performance on the simulator. 
Conversely, this result suggests that there is a gap to be filled in training medical students 
to effectively locate ventricles early on in their careers. 
Following the simulation study, analysis of the TAM responses revealed positive 
trends in the perceived efficacy of the simulator. All TAM responses had a mean greater 
than 3, suggesting that the model is better than the status quo in ventriculostomy education. 
All questions coded as perceived usefulness, attitude, and intent-to-use had means equal to 
or greater than 4.0 (positive) with standard deviations at or below 1.0. The positive trends 
in the TAM responses are evidence of the simulacrum’s efficacy.  
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There are several limitations to the current simulator model. First, the material 
properties of the brain analogue are not philologically accurate. The human brain is not a 
homogenous medium with anisotropic material properties. The medium that we have 
developed are similar to other hydrogel models [63], [76]–[78] that use a homogenous 
mixture to achieve a constant tactile response. This moderate sacrifice in realism was made 
to reduce material costs.  
Secondly, the simulacrum simulates neither dura nor arachnoid mater. These 
meningeal layers encapsulate the sub-arachnoid space, which may also exhibit increased 
CSF pressure in the presence of trauma or disease. Current 3D printing processes make this 
component of the simulacrum both challenging and impractical to model. Nevertheless, the 
authors are investigating other casting methods to develop a cost-effective process for 
simulating arachnoid dissection in future iterations of the simulacrum. Multi-material 3D 
printing may be another method of simulating the complex stratification and presentation 
of multiple tissues. Specifically, Digital Material printing (Stratasys, Rehovot, Israel) 
utilizes a series of photopolymers with a spectrum of Shore hardnesses and other material 
properties. Future computational modeling schemes may leverage volumetric modeling as 
opposed to surface mesh modeling to facilitate this multi-material printing. Current 
mechanisms for multi-material printing require discrete regions describing material 
properties. A volumetric modeling approach, where voxels can be assigned material 
properties, may result in a print with a gradient of material properties. For simulacra where 
cost considerations are less critical, this 3D printing modality may enable the construction 
of a higher fidelity simulacra. 
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Another limitation is geometric idealization (to facilitate cost-effective casting 
process). When reconstructing the brain matter, the inner surfaces of sulci were removed. 
The final representation includes gyri and impressions of the sulci for the purposes of 
surface landmarks. While virtual, haptic systems may be able to capture this form of 
undercut geometry, collaborating neurosurgeons considered these components less 
important than the cost-effective nature of the simulacrum. The current model only 
contains the superior lateral horns of the ventricles. Recent advances in elastomeric printing 
may make these geometric sacrifices unnecessary; however, it will be up to institutions to 
balance cost with geometric and tactile accuracy. 
A limitation to the TAM used to validate the potential efficacy of the simulacra 
relates to the study size. Only 10 individuals trialed the simulator and provided feedback. 
The intent of the study was to provide early qualitative support for the simulator, which 
was favorable. To better gauge the efficacy of the simulator, a multi-cohort, randomized 




EVD placement is one of the most common (yet challenging), life-saving procedures 
performed by a neurosurgeon, and also one of the first learned in residency training. Since 
cadaveric models do not reflect “live” or “real-time” anatomical functions of the 
ventricular system, simulators are a promising route for medical students and interns to 
learn this high-risk procedure. Haptic-based systems, while effective, have high associated 
costs. We have developed a low-cost simulacrum to train medical students and 
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neurosurgical residents in ventriculostomy placement. While 3D printing techniques have 
enabled anatomical representation, such as the PHDMs, 3D printing can also address more 
complex educational systems. Advanced 3D printing and casting techniques enabled the 
creation of a cost-effective simulator with advantageous realism in comparison to state-of-
the-art virtual and/or mixed alternatives. An initial qualitative study suggests that the 
simulacrum may be valuable for neurosurgical education. Future models will aim to 
enhance anatomical and physiological accuracy by adding the complete ventricular system, 
as well as additional cranial and brain tissues (e.g., scalp and meninges). 
  




5.1 Future Development of PHDMs 
 
The PHDM methods and results in this dissertation illustrate a window into an active 
translational research initiative. The research has been integrated into clinical and 
continues to impact patient care and education at collaborating institutions. Despite the 
high acceptance of this technology at collaborating institutions, PHDMs are not standard-
of-care at all major institutions. The greater challenge in any novel biomedical application 
development, not just PHDM development, is to achieve technological adoption by the 
greater community. 
 Towards this aim of technological acceptance, the PHDMs will be used in a multi-
center clinical trial. The immediate goal will be to elucidate the impact of the PHDMs on 
measurable surgical outcomes. This effort will require a prospective study design that 
rigorously blocks out confounding factors, leaving the analysis to focus on the direct, 
measurable impact by PHDMs. The results and discussion in Sections 2.4 and 2.5 have 
already informed the inclusion and exclusion criteria of the proposed clinical trial in order 
to address these potentially confounding factors. For example, additional exclusion criteria 
is expected to remove outliers from simple surgeries. Removal of outliers is expected to 
homogenize response variance, yielding stronger statistical correlation to real-world 
effects.  
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 The potential impact of the clinical trial should not be understated. Positive results 
of a clinical trial will be used to leverage the American Medical Association to develop 
Current Procedural Terminology (CPT) codes for the 3D printing technology. Following 
the development of CPT codes, hospitals would have a mechanism of billing PHDMs to 
insurance companies. The potential for reducing morbidity and mortality in conjunction 
with the potential cost-savings may drive additional hospitals to make 3D printing a 
standard-of-care. Therefore, this critical clinical trial will be the first major step towards 
technological adoption by the greater medical community.  
 
5.2 Future Development of Virtual Implantation 
 
The original technology acceptance model described by Davis suggests that perceived 
usefulness and perceived ease-of-use are critical to the adoption and use of a new 
technology. The results of the virtual implantation process suggests strong support for 
usefulness of the technology. This is further supported by the de facto use of the technology 
by SynCardia Systems for borderline and complex cases. The perceived ease-of-use was 
also positive according to clinical collaborators; however, the workflow for the technology 
may be perceived as inefficient due to the number of people needed for the virtual surgery. 
 The virtual implantation process in its current iteration requires an individual with 
advanced computational modeling skills. These skills may be common for a biomedical 
engineer; however, they are uncommon for a medical professional. The expedient fix we 
have developed is to have a two-person team addressing virtual implantation needs. The 
skilled engineer reconstructs the anatomy and manipulates the orientation of the device 
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guided by feedback from the clinician. Miscommunications when talking about translation 
and rotation in a virtual, 3D environment were common in our experience. The ideal route 
would be a clinician directly engaging with an easy-to-use technology, removing the need 
for an engineer intermediary. 
 To meet this clinical need, an interdisciplinary team is developing a virtual reality 
(VR) experience. The VR experience includes a headset that a clinician would engage with 
to view the virtual environment and reconstructed anatomy in stereoscopic vision. Infra-
red hand-tracking devices would track the clinicians’ hand movements. The clinician 
would engage with both tools in order to translate and rotate a virtual replica of the medical 
device into the patient’s reconstructed anatomy. The result of this technology would enable 
the clinician to directly interface with the virtual implantation technology, enhancing the 
workflow process and augmenting the technological ease-of-use. With regards to the 
technology acceptance model, the enhanced ease-of-use will ultimately lead to greater 
adoption of this life-saving virtual surgery technology.  
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APPENDIX A 
ANOVA TABLES FOR SURGICAL PLANNING RELATED OUTCOMES 
  
  120 
Operating room length of time (PHDM vs Traditional Planning): Tetralogy of Fallot 
with Pulm Atresia or Pulm Absent Valve  
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 352     352.1 0.03 0.855 
Error 14 142514   10179.5   
Total 15 142866    
      
Planning N Mean 
(minutes) 
StDev 95 CI  
Traditional 12 365.1 106.4 (302.6, 427.6)  




Case length of time (PHDM vs Traditional Planning): Tetralogy of Fallot with Pulm 
Atresia or Pulm Absent Valve 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 6.8    6.75 0.00 0.976 
Error 14 99161.0 7082.93   
Total 15 99167.8    
      
Planning N Mean 
(minutes) 
StDev 95 CI  
Traditional 12 257.0 84.7 (204.9, 309.1)  
PHDM 4 255.5 82.2 (165.2, 345.8)  
 
 
Operating room length of time (PHDM vs Traditional Planning): Pulmonary 
Atresia with Ventricular Septal Defects and Muliple Aorto Pulmonary collateral 
arteries (pseudotruncus) 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 22614      22614      1.25 0.301 
Error 7 127034    18148   
Total 8 149648    
      
Planning N Mean 
(minutes) 
StDev 95 CI  
Traditional 2 527.0 99.0 (301.8, 752.2)  
PHDM 7 406.4 139.8 (286.0, 526.8)  
 
 
  121 
Case length of time (PHDM vs Traditional Planning): Pulmonary Atresia with 
Ventricular Septal Defects and Muliple Aorto Pulmonary collateral arteries 
(pseudotruncus): 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 26811    26811      1.53 0.256 
Error 7 122477    17497   
Total 8 149289    
      
Planning N Mean 
(minutes) 
StDev 95 CI  
Traditional 2 425.0 79.2 (203.8, 646.2)  
PHDM 7 293.7 139.2 (175.5, 411.9)  
 
 
Operating room length of time (PHDM vs Traditional Planning): Vascular ring 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 0.12   0.12  0.00  0.944 
Error 13 25851.5    1988.58   
Total 14 25851.6    
      
Planning N Mean 
(minutes) 
StDev 95 CI  
Traditional 11 179.5 48.6 (150.4, 208.5)  
PHDM 4 179.3 27.5 (131.1, 227.4)  
 
 
Case length of time (PHDM vs Traditional Planning): Vascular ring  
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 2815     2815     1.93   0.188 
Error 13 18973     1459   
Total 14 21788    
      
 Planning N Mean 
(minutes) 
StDev 95 CI  
Traditional 11 98.7 41.9 (73.8, 123.6)  
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Operating room length of time (PHDM vs Traditional Planning): Single ventricle 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 26 25.74 0.00 0.956 
Error 86 723959   8418.13   
Total 87 723985    
      
Planning N Mean 
(minutes) 
StDev 95 CI  
Traditional 74 322.1 88.7 (300.9, 343.3)  
PHDM 14 320.6 107.1 (271.9, 369.4)  
 
 
Case length of time (PHDM vs Traditional Planning): Single ventricle 
 
Source D.F. Adj. S.S. Adj. M.S. F-Value P-Value 
PHDM 1 110 110.4 0.02 0.896 
Error 86 551501     6412.8   
Total 87 551612    
      
Planning N Mean 
(minutes) 
StDev 95 CI  
Traditional 74 217.42 77.97 (198.91, 235.92)  
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APPENDIX B 
NURSE EDUCATION ASSESSMENT 
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The pre- and post-assessment used in Section 2.6 is reproduced here in its original 
formatting. 
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